STOCK TITAN

AZIO AI Holdings issues going-concern warning

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AZIO AI Holdings reported nine-month sales rose to $6,783,779 from $3,450,056 in 2025, while net loss narrowed to $16,365,922 from $25,540,675. Operating cash use increased to $11,665,967 from $6,295,792, and accumulated deficit was $128,954,382 at September 30, 2026. One related-party customer accounted for 100% of medical-supplies revenue. Management said these conditions raise substantial doubt about its ability to continue as a going concern; its plans were not considered probable of being fully implemented sufficiently to alleviate that doubt within the applicable assessment period.

AZIO completed its July 2, 2026 acquisition of Legacy Azio AI, issuing 2,460,351 common shares and 973,450 non-voting Series A preferred shares. Each preferred share may convert into 100 common shares upon stockholder approval; if converted, former Legacy Azio holders would own approximately 85% of AZIO. The preliminary acquisition allocation included $6,503,331 of goodwill.

Under a September 25, 2026 standby equity purchase agreement, AZIO may request up to $50 million in share purchases, subject to conditions. The investor received warrants for 1,735,758 shares at $0.01 each, and AZIO agreed to file a resale registration statement covering up to 28,000,000 shares.

2 points · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 2 points

How the balance works

Positive

  • Major pointNine-month net loss narrowed to $16,365,922 from $25,540,675.
  • Moderate pointNine-month sales rose to $6,783,779 from $3,450,056.

Negative

  • Major pointOperating cash use rose to $11,665,967 from $6,295,792.
  • Major pointAZIO reported substantial doubt about its ability to continue as a going concern.
Sales, net $6,783,779 Nine months ended September 30, 2026; $3,450,056 in the corresponding 2025 period.
Net loss $16,365,922 Nine months ended September 30, 2026; $25,540,675 in the corresponding 2025 period.
Net cash used in operating activities $11,665,967 Nine months ended September 30, 2026; $6,295,792 in the corresponding 2025 period.
Accumulated deficit $128,954,382 As of September 30, 2026.
Total debt $10,332,184 As of September 30, 2026.
Series A preferred shares and conversion 973,450 shares; each convertible into 100 common shares Issued in the July 2, 2026 acquisition; conversion requires stockholder approval.
SEPA share-purchase commitment Up to $50 million Subject to conditions under the September 25, 2026 agreement.
Shares covered by agreed resale registration Up to 28,000,000 shares AZIO agreed to file a registration statement covering resale by the investor.
going concern financial
"prepared on a going concern basis"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
substantial doubt financial
"raise substantial doubt about the Company's ability to continue"
standby equity purchase agreement financial
"entered into a standby equity purchase agreement"
A standby equity purchase agreement is a contract in which an investor or group agrees to buy a company’s newly issued shares on demand, giving the company a ready source of cash it can tap when needed. Think of it like a line of credit made with stock instead of a loan: it provides financial backup but can increase the number of shares outstanding, diluting existing owners and affecting per‑share value, so investors watch these deals for their impact on ownership and earnings per share.
Exchange Cap financial
"19.9% (the “Exchange Cap”)"
fair value option financial
"elected the fair value option for the Azio Pre-paid Advance"
An accounting election that lets a company measure eligible financial assets and liabilities at their current market price, recording gains and losses in the income statement as those prices move. For investors it matters because choosing the fair value option makes reported profits and asset values respond immediately to market swings—like revaluing a house to today’s sale price—so it can increase earnings volatility while giving a more up‑to‑date view of value.
multi-period excess earnings method technical
"multi-period excess earnings method"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did AZIO report substantial doubt about its ability to continue as a going concern?

The company said substantial doubt about its ability to continue as a going concern arose from significant losses, negative operating cash flows, and reliance on improved operations and debt or equity financing. Management's plans include commissioning data-center capacity and raising capital, but were not considered probable of being implemented sufficiently to alleviate the doubt within the assessment period.

What share-purchase pricing terms apply under AZIO's September 2026 SEPA?

AZIO may choose 96% of Market Price for a same-day pricing period or 97% for a three-trading-day pricing period. Market Price is the volume-weighted average price during the same-day period for the first option, and the lowest daily volume-weighted average price during the three-day period for the second option.

What resale registration deadlines did AZIO agree to under the SEPA?

AZIO agreed to file a resale registration statement covering up to 28,000,000 shares within 30 days of September 25, 2026. It agreed to use best efforts to obtain effectiveness as soon as practicable, no later than 60 calendar days after filing or 120 days if SEC staff says it will review. If staff says it will not review or has no further comments, an earlier fifth-business-day deadline can apply.

How many common shares can each AZIO Series A preferred share convert into?

Each preferred share can convert into 100 common shares upon stockholder approval. The Series A preferred shares were non-voting at acquisition; if converted, former Legacy Azio holders would own approximately 85% of AZIO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001563568 AZIO AI HOLDINGS, INC. false --12-31 Q3 2026 6,588 6,082 5,000,000 5,000,000 0.00001 0.00001 973,450 973,450 0 0 350,000,000 350,000,000 0.00001 0.00001 17,674,960 17,674,960 7,736,129 7,736,129 4 860,428 0 2 1 3 5 5 11 5 5 5 5,000,000 0.00001 350,000,000 0.00001 0.00001 March 6, 2031 September 25, 2029 10 1 1 3 4 4 false false false false 00015635682026-01-012026-09-30 xbrli:shares 00015635682026-11-17 thunderdome:item iso4217:USD 00015635682026-09-30 00015635682025-12-31 0001563568us-gaap:RelatedPartyMember2026-09-30 0001563568us-gaap:RelatedPartyMember2025-12-31 iso4217:USDxbrli:shares 0001563568us-gaap:RelatedPartyMember2026-07-012026-09-30 0001563568us-gaap:RelatedPartyMember2025-07-012025-09-30 0001563568us-gaap:RelatedPartyMember2026-01-012026-09-30 0001563568us-gaap:RelatedPartyMember2025-01-012025-09-30 0001563568us-gaap:NonrelatedPartyMember2026-07-012026-09-30 0001563568us-gaap:NonrelatedPartyMember2025-07-012025-09-30 0001563568us-gaap:NonrelatedPartyMember2026-01-012026-09-30 0001563568us-gaap:NonrelatedPartyMember2025-01-012025-09-30 00015635682026-07-012026-09-30 00015635682025-07-012025-09-30 00015635682025-01-012025-09-30 0001563568us-gaap:CommonStockMember2025-12-31 0001563568us-gaap:PreferredStockMember2025-12-31 0001563568us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001563568azio:ConsiderationReceivableMember2025-12-31 0001563568us-gaap:RetainedEarningsMember2025-12-31 0001563568us-gaap:CommonStockMember2026-01-012026-03-31 0001563568us-gaap:PreferredStockMember2026-01-012026-03-31 0001563568us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31 0001563568azio:ConsiderationReceivableMember2026-01-012026-03-31 0001563568us-gaap:RetainedEarningsMember2026-01-012026-03-31 00015635682026-01-012026-03-31 0001563568us-gaap:CommonStockMember2026-03-31 0001563568us-gaap:PreferredStockMember2026-03-31 0001563568us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001563568azio:ConsiderationReceivableMember2026-03-31 0001563568us-gaap:RetainedEarningsMember2026-03-31 00015635682026-03-31 0001563568us-gaap:CommonStockMember2026-04-012026-06-30 0001563568us-gaap:PreferredStockMember2026-04-012026-06-30 0001563568us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-30 0001563568azio:ConsiderationReceivableMember2026-04-012026-06-30 0001563568us-gaap:RetainedEarningsMember2026-04-012026-06-30 00015635682026-04-012026-06-30 0001563568us-gaap:CommonStockMember2026-06-30 0001563568us-gaap:PreferredStockMember2026-06-30 0001563568us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001563568azio:ConsiderationReceivableMember2026-06-30 0001563568us-gaap:RetainedEarningsMember2026-06-30 00015635682026-06-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:AdditionalPaidInCapitalMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberazio:ConsiderationReceivableMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:RetainedEarningsMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberazio:AzioAiAcquisitionPreferredMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:AdditionalPaidInCapitalMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberazio:ConsiderationReceivableMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:RetainedEarningsMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberazio:AzioAiAcquisitionCommonMember2026-07-012026-09-30 0001563568us-gaap:CommonStockMember2026-07-012026-09-30 0001563568us-gaap:PreferredStockMember2026-07-012026-09-30 0001563568us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001563568azio:ConsiderationReceivableMember2026-07-012026-09-30 0001563568us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001563568us-gaap:CommonStockMember2026-09-30 0001563568us-gaap:PreferredStockMember2026-09-30 0001563568us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001563568azio:ConsiderationReceivableMember2026-09-30 0001563568us-gaap:RetainedEarningsMember2026-09-30 0001563568us-gaap:CommonStockMember2024-12-31 0001563568us-gaap:PreferredStockMember2024-12-31 0001563568us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001563568us-gaap:RetainedEarningsMember2024-12-31 00015635682024-12-31 0001563568us-gaap:CommonStockMember2025-01-012025-03-31 0001563568us-gaap:PreferredStockMember2025-01-012025-03-31 0001563568us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001563568us-gaap:RetainedEarningsMember2025-01-012025-03-31 00015635682025-01-012025-03-31 0001563568us-gaap:CommonStockMember2025-03-31 0001563568us-gaap:PreferredStockMember2025-03-31 0001563568us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001563568us-gaap:RetainedEarningsMember2025-03-31 00015635682025-03-31 0001563568us-gaap:CommonStockMember2025-04-012025-06-30 0001563568us-gaap:PreferredStockMember2025-04-012025-06-30 0001563568us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-30 0001563568us-gaap:RetainedEarningsMember2025-04-012025-06-30 00015635682025-04-012025-06-30 0001563568us-gaap:CommonStockMember2025-06-30 0001563568us-gaap:PreferredStockMember2025-06-30 0001563568us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001563568us-gaap:RetainedEarningsMember2025-06-30 00015635682025-06-30 0001563568us-gaap:CommonStockMember2025-07-012025-09-30 0001563568us-gaap:PreferredStockMember2025-07-012025-09-30 0001563568us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001563568us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001563568us-gaap:CommonStockMember2025-09-30 0001563568us-gaap:PreferredStockMember2025-09-30 0001563568us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001563568us-gaap:RetainedEarningsMember2025-09-30 00015635682025-09-30 0001563568azio:UsEnvironmentalProtectionAgencyEpaSchoolBusContractMember2026-01-012026-09-30 0001563568azio:UsEnvironmentalProtectionAgencyEpaSchoolBusContractMember2025-01-012025-09-30 0001563568us-gaap:PrivatePlacementMember2026-01-012026-09-30 0001563568us-gaap:PrivatePlacementMember2025-01-012025-09-30 0001563568azio:DebenturesMember2026-01-012026-09-30 0001563568azio:DebenturesMember2025-01-012025-09-30 0001563568azio:OtherDebtMember2026-01-012026-09-30 0001563568azio:OtherDebtMember2025-01-012025-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001563568azio:LegacyAzioAiMember2026-01-012026-09-30 0001563568azio:LegacyAzioAiMember2025-01-012025-09-30 0001563568azio:ConversionOfConvertibleNoteMember2026-01-012026-09-30 0001563568azio:ConversionOfConvertibleNoteMember2025-01-012025-09-30 0001563568azio:PartialRepaymentOfDebenturesThroughCommonStockIssuanceMember2026-01-012026-09-30 0001563568azio:PartialRepaymentOfDebenturesThroughCommonStockIssuanceMember2025-01-012025-09-30 0001563568azio:ConsultingtypeServicesMember2026-01-012026-09-30 0001563568azio:ConsultingtypeServicesMember2025-01-012025-09-30 xbrli:pure 0001563568srt:ScenarioPreviouslyReportedMember2026-04-012026-06-30 0001563568srt:ScenarioPreviouslyReportedMember2026-06-30 0001563568srt:RestatementAdjustmentMember2026-07-012026-09-30 0001563568azio:ElectricVehiclesMember2026-07-012026-09-30 0001563568azio:ElectricVehiclesMember2026-01-012026-09-30 0001563568azio:ElectricVehiclesMember2025-07-012025-09-30 0001563568azio:ElectricVehiclesMember2025-01-012025-09-30 0001563568azio:DeliveryOfMedicalSuppliesMember2026-07-012026-09-30 0001563568azio:DeliveryOfMedicalSuppliesMember2026-01-012026-09-30 0001563568azio:DeliveryOfMedicalSuppliesMember2025-07-012025-09-30 0001563568us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberazio:MedicalSuppliesMember2026-01-012026-09-30 0001563568azio:AiDataInfrastructureMember2026-07-012026-09-30 0001563568azio:AiDataInfrastructureMember2026-01-012026-09-30 0001563568azio:ElectricVehiclesMember2026-07-012026-09-30 0001563568azio:ElectricVehiclesMember2026-01-012026-09-30 0001563568azio:UsEnvironmentalProtectionAgencyEpaSchoolBusContractMember2026-09-30 0001563568azio:UsEnvironmentalProtectionAgencyEpaSchoolBusContractMember2025-12-31 0001563568azio:AccountsPayableConcentrationMemberus-gaap:SupplierConcentrationRiskMember2026-01-012026-09-30 0001563568azio:AccountsPayableConcentrationMemberus-gaap:SupplierConcentrationRiskMemberazio:OneVendorMember2026-01-012026-09-30 0001563568azio:AccountsPayableConcentrationMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-12-31 0001563568azio:AccountsPayableConcentrationMemberus-gaap:SupplierConcentrationRiskMemberazio:TwoVendorsMember2025-01-012025-12-31 0001563568us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberazio:OneCustomerMemberus-gaap:RelatedPartyMember2026-01-012026-09-30 utr:Y 0001563568srt:MinimumMember2026-09-30 0001563568srt:MaximumMember2026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMember2026-07-022026-07-02 0001563568azio:LegacyAzioAiMember2026-07-02 0001563568azio:LegacyAzioAiMember2026-07-022026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:SeriesAPreferredStockMember2026-07-022026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:SeriesAPreferredStockMember2026-07-02 0001563568azio:LegacyAzioAiMemberazio:AzioCorporationMember2026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMember2026-07-022026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMember2026-07-022026-07-02 0001563568azio:PreclosingStockholdersMemberazio:AzioCorporationMember2026-07-02 0001563568azio:OfficersAndDirectorsWhoAgreedInSupportAgreementsMemberazio:AzioCorporationMember2026-07-02 0001563568azio:AccelVentureIiiMemberazio:AzioCorporationMember2026-07-02 0001563568azio:AccelVentureIiiMemberazio:AzioCorporationMember2026-07-02 0001563568azio:LegacyAzioAiMember2026-06-30 0001563568azio:LegacyAzioAiMember2026-01-012026-06-30 0001563568azio:LegacyAzioAiMember2026-06-30 0001563568azio:LegacyAzioAiMember2026-01-012026-06-30 00015635682025-01-012025-12-31 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMember2026-07-022026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:CustomerContractsMemberus-gaap:MeasurementInputDiscountRateMember2026-07-02 0001563568azio:LegacyAzioAiMemberus-gaap:CustomerContractsMember2026-07-02 0001563568azio:LegacyAzioAiMemberazio:SupplierRelationshipsMemberus-gaap:MeasurementInputDiscountRateMember2026-07-02 0001563568azio:LegacyAzioAiMemberazio:SupplierRelationshipsMember2026-07-02 0001563568us-gaap:CustomerContractsMember2026-09-30 0001563568us-gaap:CustomerContractsMembersrt:WeightedAverageMember2026-09-30 0001563568azio:SupplierRelationshipsMember2026-09-30 0001563568azio:SupplierRelationshipsMembersrt:WeightedAverageMember2026-09-30 0001563568us-gaap:TrademarksAndTradeNamesMember2026-09-30 0001563568us-gaap:TrademarksAndTradeNamesMembersrt:WeightedAverageMember2026-09-30 0001563568us-gaap:FurnitureAndFixturesMember2026-09-30 0001563568us-gaap:FurnitureAndFixturesMember2025-12-31 0001563568us-gaap:LeaseholdImprovementsMember2026-09-30 0001563568us-gaap:LeaseholdImprovementsMember2025-12-31 0001563568us-gaap:MachineryAndEquipmentMember2026-09-30 0001563568us-gaap:MachineryAndEquipmentMember2025-12-31 0001563568us-gaap:VehiclesMember2026-09-30 0001563568us-gaap:VehiclesMember2025-12-31 0001563568us-gaap:ConstructionInProgressMember2026-09-30 0001563568us-gaap:ConstructionInProgressMember2025-12-31 0001563568azio:TestdemoVehiclesMember2026-09-30 0001563568azio:TestdemoVehiclesMember2025-12-31 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:August2025PremiumFinancingAgreementMember2025-08-20 utr:M 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:PremiumFinancingAgreementMember2023-08-202023-08-20 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:PremiumFinancingAgreementMember2023-08-20 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:August2025PremiumFinancingAgreementMember2024-08-202024-08-20 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:August2025PremiumFinancingAgreementMember2024-08-20 0001563568azio:AfcoInsurancePremiumFinanceMemberazio:August2025PremiumFinancingAgreementMember2026-06-30 0001563568azio:IpfsCorporationMemberazio:January2026PremiumFinancingAgreementMember2026-01-01 0001563568azio:IpfsCorporationMemberazio:January2026PremiumFinancingAgreementMember2026-01-012026-01-01 0001563568azio:IpfsCorporationMemberazio:January2026PremiumFinancingAgreementMember2026-09-30 0001563568azio:MiscellaneousNotesPayableMember2026-09-30 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ArSepaMember2024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PrepaidAdvanceUnderArSepaForPromissoryNotesMember2024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PrepaidAdvanceUnderArSepaForPromissoryNotesMember2024-10-312024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PrepaidAdvanceUnderArSepaTrancheOneMember2024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PrepaidAdvanceUnderArSepaTrancheTwoMember2024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PromissoryNotesMember2024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PromissoryNotesMember2024-10-312024-10-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv1PromissoryNoteIntoCommonStockMember2025-01-012025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv1PromissoryNoteIntoCommonStockMember2025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:PrepaidAdvanceUnderArSepaTrancheOneMember2025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv1PromissoryNoteIntoCommonStockMember2026-01-012026-03-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv1PromissoryNoteIntoCommonStockMember2026-03-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:AdditionalPromissoryNoteMember2025-02-24 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:AdditionalPromissoryNoteMember2025-02-242025-02-24 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:AdditionalPromissoryNoteTrancheOneMember2025-02-25 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:AdditionalPromissoryNoteTrancheOneMember2025-02-252025-02-25 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv3PromissoryNoteIntoCommonStockMember2025-01-012025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv3PromissoryNoteIntoCommonStockMember2025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:AdditionalPromissoryNoteTrancheOneMember2025-12-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv3PromissoryNoteIntoCommonStockMember2026-01-012026-03-31 0001563568azio:CaymanIslandsExemptLimitedCompanyMemberazio:ConversionOfEvtv3PromissoryNoteIntoCommonStockMember2026-03-31 0001563568azio:PrepaidAdvancesMemberazio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-25 0001563568azio:PrepaidAdvancesMemberazio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-252026-09-25 0001563568azio:PrepaidAdvancesMemberazio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-27 0001563568azio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-252026-09-25 0001563568azio:InvestorWarrantsMemberazio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-25 0001563568azio:AmendedAndRestatedStandbyEquityPurchaseAgreementMember2026-09-30 0001563568azio:RegistrationRightsAgreementMember2026-09-25 0001563568azio:RegistrationRightsAgreementMember2026-07-012026-09-30 0001563568azio:RegistrationRightsAgreementMember2026-01-012026-09-30 0001563568azio:DebenturesMember2026-03-06 0001563568azio:DebenturesMemberazio:FirstClosingDebenturesMember2026-03-06 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-03-06 0001563568azio:DebenturesMember2026-03-062026-03-06 0001563568us-gaap:InvestorMemberazio:DebenturesMember2026-03-062026-03-06 0001563568azio:FirstClosingBuyerWarrantsMember2026-03-06 0001563568azio:DebenturesMemberazio:FirstClosingDebenturesMember2026-03-062026-03-06 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-03-062026-03-06 0001563568azio:DebenturesMemberazio:FirstClosingDebenturesMember2026-01-012026-03-31 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-05-062026-05-06 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-05-06 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-07-012026-09-30 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-01-012026-09-30 0001563568azio:DebenturesMemberazio:SecondClosingDebenturesMember2026-09-30 0001563568us-gaap:RevolvingCreditFacilityMemberazio:AzioCorporationMemberus-gaap:SubsequentEventMember2026-10-21 0001563568us-gaap:RevolvingCreditFacilityMemberazio:AzioCorporationMemberus-gaap:SubsequentEventMember2026-10-212026-10-21 0001563568azio:CompanyMemberus-gaap:SubsequentEventMemberazio:ChiefBusinessDevelopmentOfficerMember2026-10-21 0001563568us-gaap:RevolvingCreditFacilityMemberazio:AzioCorporationMember2026-09-30 0001563568azio:February2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-02-12 0001563568azio:February2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-02-122026-02-12 0001563568azio:February2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-09-30 0001563568azio:February2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-07-012026-09-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-04-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-04-302026-04-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-09-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:ConvertibleDebtMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001563568azio:LegacyAzioAiMemberus-gaap:CommonStockMember2026-07-012026-09-30 0001563568us-gaap:CommonStockMember2026-01-012026-09-30 0001563568azio:ConversionOfDebenturesIntoCommonStockMember2026-01-012026-09-30 0001563568azio:ConversionOfConvertibleDebtIntoCommonStockMember2026-01-012026-09-30 0001563568azio:DebentureWarrantsMember2026-04-012026-06-30 0001563568azio:DebentureWarrantsMember2026-06-30 0001563568azio:DebentureWarrantsMember2026-07-012026-09-30 0001563568azio:DebentureWarrantsMember2026-09-30 0001563568azio:WarrantOneMember2026-09-30 0001563568azio:WarrantOneMember2026-01-012026-09-30 0001563568azio:WarrantTwoMember2026-09-30 0001563568azio:WarrantTwoMember2026-01-012026-09-30 0001563568azio:FirstClosingBuyerWarrantsMember2026-04-012026-06-30 0001563568azio:FirstClosingBuyerWarrantsMember2026-07-012026-09-30 0001563568azio:FirstClosingBuyerWarrantsMember2026-09-30 0001563568azio:InvestorWarrantsMember2026-09-30 0001563568azio:OptionAt219Member2026-01-012026-09-30 0001563568azio:OptionAt2200Member2026-01-012026-09-30 0001563568azio:OptionAt1500Member2026-01-012026-09-30 0001563568azio:OptionAt2200TwoMember2026-01-012026-09-30 0001563568azio:OptionAt9000Member2026-01-012026-09-30 0001563568azio:OptionAt2000Member2026-01-012026-09-30 0001563568azio:OptionAt2400Member2026-01-012026-09-30 0001563568azio:OptionAt2100Member2026-01-012026-09-30 0001563568azio:OptionAt2110Member2026-01-012026-09-30 0001563568azio:OptionAt9000Member2026-09-30 0001563568azio:OptionAt26200Member2026-09-30 0001563568azio:OptionAt26200Member2026-01-012026-09-30 0001563568azio:OptionAt2100Member2026-09-30 0001563568azio:OptionAt2110Member2026-09-30 0001563568azio:OptionAt2660Member2026-09-30 0001563568azio:OptionAt2660Member2026-01-012026-09-30 0001563568azio:OptionAt2750Member2026-09-30 0001563568azio:OptionAt2750Member2026-01-012026-09-30 0001563568azio:OptionAt1760Member2026-09-30 0001563568azio:OptionAt1760Member2026-01-012026-09-30 0001563568azio:OptionAt1490Member2026-09-30 0001563568azio:OptionAt1490Member2026-01-012026-09-30 0001563568azio:OptionAt250Member2026-09-30 0001563568azio:OptionAt250Member2026-01-012026-09-30 0001563568azio:OptionsAt212Member2026-09-30 0001563568azio:OptionsAt212Member2026-01-012026-09-30 0001563568azio:OptionAt219Member2026-09-30 0001563568us-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-05-222026-05-22 0001563568us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-05-222026-05-22 0001563568azio:PerformanceOptionsMember2024-02-282024-02-28 00015635682026-07-312026-07-31 0001563568azio:ServicebasedAwardMember2026-09-30 0001563568azio:TwoVehiclesMemberazio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2020-01-01 0001563568azio:TrailerMemberazio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2019-12-01 0001563568azio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2019-12-01 0001563568azio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2026-07-012026-09-30 0001563568azio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2026-01-012026-09-30 0001563568azio:SRIEquipmentLeasesMemberazio:SriProfessionalServicesIncorporatedMember2025-01-012025-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2020-04-01 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2026-07-012026-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2025-07-012025-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2026-01-012026-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2025-01-012025-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2026-09-30 0001563568azio:ABCIOfficeLeaseMemberazio:AlphaBravoCharlieIncAbciMember2025-12-31 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2026-07-012026-09-30 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2025-07-012025-09-30 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2026-01-012026-09-30 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2025-01-012025-09-30 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2026-09-30 0001563568us-gaap:RelatedPartyMembersrt:PresidentMember2025-12-31 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2026-07-012026-09-30 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2025-07-012025-09-30 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2026-01-012026-09-30 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2025-01-012025-09-30 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2026-09-30 0001563568us-gaap:RelatedPartyMembersrt:ChiefOperatingOfficerMember2025-12-31 0001563568azio:ListedVenturesMember2026-07-012026-09-30 0001563568azio:MiltheaCompanyMember2026-07-012026-09-30 0001563568azio:MiltheaCompanyMember2026-09-30 0001563568azio:MiltheaCompanyMember2025-12-31 0001563568azio:AloraGroupMember2026-07-012026-09-30 0001563568azio:MaddoxMedicalMember2026-01-012026-09-30 0001563568azio:MaddoxMedicalMember2025-01-012025-12-31 0001563568us-gaap:RelatedPartyMemberazio:IndependentDirectorAndChairmenOfTheAuditCommitteeMember2026-07-012026-09-30 0001563568us-gaap:RelatedPartyMemberazio:IndependentDirectorAndChairmenOfTheAuditCommitteeMember2025-07-012025-09-30 0001563568us-gaap:RelatedPartyMemberazio:IndependentDirectorAndChairmenOfTheAuditCommitteeMember2026-01-012026-09-30 0001563568us-gaap:RelatedPartyMemberazio:IndependentDirectorAndChairmenOfTheAuditCommitteeMember2025-01-012025-09-30 0001563568azio:LeaseAgreementWithCavokAirTexasLlcMember2026-04-01 0001563568azio:LeaseArrangementWithTexoilVenturesLlcMember2026-03-01 0001563568azio:SubleaseWithMaddoxDefenseMember2025-04-01 0001563568azio:February2026ConvertibleNoteMember2026-09-30 0001563568azio:February2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:February2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:February2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568azio:April2026ConvertibleNoteMember2026-09-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:April2026ConvertibleNoteMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568azio:March2026DebtNoteMember2026-09-30 0001563568azio:March2026DebtNoteMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:March2026DebtNoteMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:March2026DebtNoteMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568azio:May2026DebtNoteMember2026-09-30 0001563568azio:May2026DebtNoteMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:May2026DebtNoteMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:May2026DebtNoteMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568us-gaap:LineOfCreditMember2026-09-30 0001563568us-gaap:LineOfCreditMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568us-gaap:LineOfCreditMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568us-gaap:LineOfCreditMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568azio:SepaConvertibleDebtNoteMember2026-09-30 0001563568azio:SepaConvertibleDebtNoteMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:SepaConvertibleDebtNoteMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:SepaConvertibleDebtNoteMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568azio:OtherDebtMember2026-09-30 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel1Member2026-09-30 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel2Member2026-09-30 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel3Member2026-09-30 0001563568us-gaap:FairValueInputsLevel1Member2026-09-30 0001563568us-gaap:FairValueInputsLevel2Member2026-09-30 0001563568us-gaap:FairValueInputsLevel3Member2026-09-30 0001563568us-gaap:FairValueInputsLevel1Member2025-12-31 0001563568us-gaap:FairValueInputsLevel2Member2025-12-31 0001563568us-gaap:FairValueInputsLevel3Member2025-12-31 0001563568azio:OtherDebtMember2025-12-31 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel1Member2025-12-31 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel2Member2025-12-31 0001563568azio:OtherDebtMemberus-gaap:FairValueInputsLevel3Member2025-12-31 0001563568us-gaap:OperatingSegmentsMemberazio:ElectricVehiclesMember2026-07-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:MedicalSuppliesMember2026-07-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:AiDataInfrastructureMember2026-07-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:DronesMember2026-07-012026-09-30 0001563568us-gaap:CorporateNonSegmentMember2026-07-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:ElectricVehiclesMember2025-07-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:MedicalSuppliesMember2025-07-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:AiDataInfrastructureMember2025-07-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:DronesMember2025-07-012025-09-30 0001563568us-gaap:CorporateNonSegmentMember2025-07-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:ElectricVehiclesMember2026-01-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:MedicalSuppliesMember2026-01-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:AiDataInfrastructureMember2026-01-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:DronesMember2026-01-012026-09-30 0001563568us-gaap:CorporateNonSegmentMember2026-01-012026-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:ElectricVehiclesMember2025-01-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:MedicalSuppliesMember2025-01-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:AiDataInfrastructureMember2025-01-012025-09-30 0001563568us-gaap:OperatingSegmentsMemberazio:DronesMember2025-01-012025-09-30 0001563568us-gaap:CorporateNonSegmentMember2025-01-012025-09-30 0001563568us-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2026-10-21
 

 

Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 10-Q


☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED September 30, 2026

 

or

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                   to                         

 

Commission File Number: 001-38078

 


 

AZIO AI HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 


Delaware

46-0774222

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

7510 Ardmore Street

Houston, TX 77054

(Address of principal executive offices, including zip code)

(870) 970-3355

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

 


 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

Trading

 

Name of each exchange

Title of each class 

Symbol(s)

 

on which registered

Common Stock, par value $0.00001 per share

 

AZIO

 

Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

  

Emerging growth company

☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of the registrant’s common stock, $0.00001 par value per share, as of November 17, 2026 was 18,668,377.

 



 

 

 

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

 

TABLE OF CONTENTS

 

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED September 30, 2026

 

 

PAGE

Special Note Regarding Forward-Looking Statements 1
   
Part I. FINANCIAL INFORMATION
     

Item 1. Financial Statements:

2

 

Unaudited Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025

2

 

Unaudited Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025

3

 

Unaudited Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2026 and 2025

4

 

Unaudited Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025

5

 

Notes to Unaudited Consolidated Financial Statements

6

     

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3. Quantitative and Qualitative Disclosure about Market Risk

21

Item 4. Controls and Procedures

21

 

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

22

Item 1A. Risk Factors

22

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

22

Item 3. Defaults Upon Senior Securities

22

Item 4. Mine Safety Disclosures

22

Item 5. Other Information

22

Item 6. Exhibits

23

Signatures

24

 

i

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Quarterly Report”) of Azio AI Holdings, Inc., including its consolidated subsidiaries (the "Company,” “we,” “us,” and “our”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or our future financial performance or condition and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “contemplate,” “plan,”  “project,” “forecast,” “potential,” “possible,” “proposed,” “should,” “develop,” “opportunity,” “target,” “outlook,” “optimistic,” “poised,” “positioned,” “maintain,” “continue,”  “aim,” “goal,”  “will” and “would” or the negatives of these terms or other comparable terminology intended to identify statements about the future.

 

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Quarterly Report, including in “Risk Factors” and elsewhere, identify important factors, which you should consider in evaluating our forward-looking statements. These factors could cause actual results and events to differ materially from those expressed or implied in any forward-looking statement and include, among other things:

 

  • our ability to successfully integrate the operations, personnel, technology systems, and business culture of Legacy Azio (as defined in Note 1 to our unaudited consolidated financial statements included in this Quarterly Report) following the Azio Acquisition (as defined in Note 1 to our unaudited consolidated financial statements included in this Quarterly Report), and to realize the anticipated benefits and synergies of this acquisition within the expected timeframe, or at all, and our ability to successfully integrate and realize the benefits of future strategic acquisitions;
     
  • the possibility that the Azio Acquisition exposes us to unknown, contingent, or underestimated liabilities, including litigation, regulatory, tax, and environmental liabilities;
     
  • our ability to retain key employees, customers, and business relationships of the acquired business following the Azio Acquisition;
     
  • potential impairment charges relating to goodwill or other intangible assets recognized in connection with the Azio Acquisition if the acquired business does not perform as expected;
     
  • our limited operating history and unproven strategy in our AI data center, GPU compute, and digital power business, and our ability to develop and operate large-scale, power-intensive AI data center campuses on time and within budget;
     
  • our reliance on a concentrated customer and counterparty base for our GPU sales and infrastructure agreements, and our dependence on a limited number of suppliers for GPUs and related hardware;
     
 

•

our ability to generate demand for our products in order to generate revenue;

 

 

•

our need for significant additional capital to fund our AI infrastructure and digital power buildout, which may not be available on acceptable terms, or at all;

 

 

•

our ability to effectively execute our business strategy;

 

 

•

our ability and our suppliers’ ability to scale our manufacturing and assembling processes effectively and quickly;

 

 

•

our ability to manage our expansion, growth and operating expenses and reduce and adequately control the costs and expenses associated with operating our business;

     
  • the potential impact of product recalls and product liability claims relating to the products we distribute and other litigation;

 

 

•

our ability and our manufacturing partners’ ability to navigate disruptions to the global supply chain and procure the raw materials, parts, and components necessary to produce our products on terms acceptable to us and our customers;

     
  • the volatility of digital asset prices and the regulatory treatment of our digital asset mining operations, and our ability to reallocate power and computing capacity between AI and digital asset mining uses;

 

 

•

our ability to obtain, retain and grow our customers;

 

  • our dependence on a reliable, cost-effective, and scalable supply of electricity for our AI data center, GPU compute, and digital asset mining operations, and regulatory or grid operator actions affecting large electricity loads;
     
 

•

our ability to enter into, sustain and renew strategic relationships on favorable terms;

     
  • our dependency on, and retention of, key personnel;

 

 

•

our ability to achieve and sustain profitability;

     
  • the impact of legislation and/or government regulation on our business and industry, including, without limitation, the regulatory treatment of data mining operations, the status of government subsidies, rebates and economic incentives that support the development and demand for our products and services within our electric vehicles segment and our ability to obtain required governmental authorizations for the sale and distribution of our drones;
     
  • our compliance with foreign laws and regulations related to the international expansion of our drone division;
     
  • ongoing and anticipated changes in the U.S. political environment and changes to regulatory agencies;
     
  • changes in trade policies and the imposition of tariffs and other trade barriers in the jurisdictions where we source our materials or sell our products;

 

 

•

our ability to evaluate and measure our current business and future prospects;

 

 

•

our ability to compete and succeed in highly competitive and evolving industries;

 

 

•

our ability to respond and adapt to changes in technology, including the rapid technological change in AI hardware that could render our GPU and data center infrastructure obsolete;

     
  • the cost and adequacy of insurance coverage and increases in the number or severity of insurance and claims expenses;

 

 

•

our ability to protect our intellectual property and to develop, maintain and enhance strong brands;

     
  • disruptions in our information technology systems, including, but not limited to, system failures, cyber-attacks, unauthorized physical or electronic access, or other natural or man-made incidents or disasters; and
     
  • our ability to maintain compliance with the listing requirements of The Nasdaq Stock Market LLC (“Nasdaq”) and the impact of any steps taken to maintain such compliance on our operations, stock price and future access to capital.

 

You should read this Quarterly Report and the documents that we reference elsewhere in this Quarterly Report completely and with the understanding that our actual results may differ materially from what we expect as expressed or implied by our forward-looking statements. Forward-looking statements are subject to a number of known and unknown risks, uncertainties, assumptions and other important factors, including, but not limited to, those discussed in Part I, Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) and in Part II, Item 1A (Risk Factors) of this Quarterly Report as well as in Part I, Item 1 (Business) and Item 1A (Risk Factors) and Part II, Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations) of our Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on April 13, 2026 (the "2025 Annual Report"). In light of the significant risks and uncertainties to which our forward-looking statements are subject, you should not place undue reliance on such forward-looking statements or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. These forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report regardless of the time of delivery of this Quarterly Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this Quarterly Report.

 

Unless expressly indicated or the context requires otherwise, references in this Quarterly Report to “Azio AI,” the “Company,” “we,” “our,” and “us” refer to Azio AI Holdings, Inc., a Delaware corporation, and our consolidated subsidiaries, unless the context indicates otherwise.

 

 

1

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(unaudited)

 

  

September 30,

  

December 31,

 
  

2026

  

2025

 

ASSETS

        

Current assets:

        

Cash

 $1,145,367  $358,966 

Receivable from related party, net of allowance of $6,588 and $6,082 respectively

  1,847,685   1,196,253 

EPA fulfillment asset

  1,342,966   1,503,477 

Prepaid expenses

  230,303   237,610 

Other current assets

  700,615   188,074 

Total current assets

 $5,266,936  $3,484,380 

Property and equipment, net

  1,385,471   475,959 

Right-of-use asset

  1,803,493   485,482 

Goodwill

  6,503,331   — 

Intangible assets, net

  18,497,095   — 

Other non-current assets

  221,995   221,995 

Total assets

 $33,678,321  $4,667,816 
         

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

        

Current liabilities:

        

Accounts payable

 $5,264,021  $3,581,715 

Deferred revenue

  1,544,000   1,544,000 

EPA contract liability

  5,146,066   5,169,691 

Accrued liabilities

  1,913,514   2,257,953 

Operating lease liability - short-term

  742,008   229,899 

Line of credit facility from related party

  1,765,000   — 

Debt - current

  8,290,863   505,759 

Total current liabilities

  24,665,472   13,289,017 

Long-term liabilities

        

Operating lease liability - long-term

  801,294   306,904 

Convertible Notes

  276,321   — 

Deferred tax liability

  3,883,949   — 

Total liabilities

  29,627,036  $13,595,921 
         

Stockholders’ Equity/(Deficit):

        

Preferred stock, 5,000,000 authorized, $0.00001 par value per share, 973,450 issued and outstanding as of September 30, 2026, and 0 as of December 31, 2025

  10   — 
         

Common stock, 350,000,000 authorized, $0.00001 par value per share, 17,674,960 and 7,736,129 issued and outstanding as of September 30, 2026, and December 31, 2025, respectively

  178   78 

Additional paid-in capital

  133,005,479   103,660,277 

Accumulated deficit

  (128,954,382)  (112,588,460)

Total stockholders’ equity/(deficit)

  4,051,285   (8,928,105)

Total liabilities and stockholders’ equity/(deficit)

 $33,678,321  $4,667,816 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

2

 

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

  

For the Three Months Ended

  

For the Nine Months Ended

 
  

September 30,

  

September 30,

  

September 30,

  

September 30,

 
  

2026

  

2025

  

2026

  

2025

 

Sales, net to related party

 $1,872,271  $1,812,461  $6,783,779  $3,101,993 

Sales, net

  —   —   —   348,063 

Cost of sales

  1,909,668   1,731,667   6,938,459   4,707,588 

Gross (loss) profit

  (37,397)  80,794   (154,680)  (1,257,532)
                 

Operating expenses

                

General and administrative

  6,118,769   2,781,148   15,487,635   9,136,044 

Consulting

  —   18,750   —   65,261 

Research and development

  12,000   43,289   34,000   731,808 

Goodwill impairment charge

  —   —   —   10,103,048 

Impairment of intangible assets

  —   3,300,801   —   3,300,801 

Total operating expenses, net

  6,130,769   6,143,988   15,521,635   23,336,962 

Loss from operations

 $(6,168,166) $(6,063,194) $(15,676,315) $(24,594,494)

Other (expenses)/income:

                

Interest income (expense), net

  —   21,979   50   33,035 

Gain/(Loss) in settlement of debt and changes in fair value of debt

  330,175   (312,812)  (670,452)  (963,513)

Other expenses

  (11,743)  (3,530)  (127,356)  (15,703)

Total other income/(expenses)

 $318,432  $(294,363) $(797,758)  (946,181)

Loss before income taxes

  (5,849,734)  (6,357,557)  (16,474,073)  (25,540,675)

Income tax expense/(benefit)

  (108,151)  —   (108,151)  — 

Net loss

 $(5,741,583) $(6,357,557) $(16,365,922) $(25,540,675)

Net loss per share to common stockholders:

                

Basic and diluted

 $(0.34) $(1.79) $(1.15) $(9.20)

Weighted average shares used in the computation of net loss per share:

                

Basic and diluted

  16,899,321   3,557,789   14,217,115   2,776,625 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

3

 

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Three and Nine Months Ended September 30, 2026 and 2025

(unaudited)

 

                  

Additional

             
  

Common Stock

  

Preferred Stock

  

Paid-In

  

Consideration

  

Accumulated

  

Stockholders’

 
  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Receivable

  

Deficit

  

Equity/(Deficit)

 

Balance, December 31, 2025

  7,736,129  $78   —  $—  $103,660,277  $—  $(112,588,460) $(8,928,105)

Common stock issued for cash

  4,570,837   46   —   —   2,677,044   —   —   2,677,090 

Common stock issued from convertible notes conversion

  623,753   6   —   —   358,652   —   —   358,658 

Warrants issued in conjunction with debentures

  —   —   —   —   606,921   —   —   606,921 

Warrants issued as financing costs

  —   —   —   —   1,070,464   —   —   1,070,464 

Stock based compensation

  —   —   —   —   25,508   —   —   25,508 

Net loss

  —   —   —   —   —   —   (3,986,923)  (3,986,923)

Balance, March 31, 2026

  12,930,719  $130   —  $—  $108,398,866  $—  $(116,575,383) $(8,176,387)

Common stock issued for cash

  20,000   —   —   —   47,716   —   —   47,716 

Warrants exercised

  291,778   3   —   —   2,915   —   —   2,918 

Partial repayment of debenture through common stock issuance

  435,000   4   —   —   702,135   —   —   702,139 

Stock based compensation

  —   -   —   —   1,678,036   —   —   1,678,036 

Net loss

  —   -   —   —   —   —   (6,637,416)  (6,637,416)

Balance, June 30, 2026

  13,677,497  $137   —  $—  $110,829,668  $—  $(123,212,799) $(12,382,994)

Preferred stock issued - Azio AI acquisition

  —   —   973,450   10  $13,590,890   —   —   13,590,900 

Common stock issued - Azio AI acquisition

  2,460,351   25   —   —   4,108,762   —   —   4,108,787 

Warrants exercised

  450,000   5   —   —   4,496   —   —   4,501 

Warrants issued in conjunction with convertible notes

  —   —   —   —   1,892,068   —   —   1,892,068 

Warrants issued as financing costs

  —   —   —   —   315,275   —   —   315,275 

Common stock issued for cash

  201,256   2   —   —   250,192   —   —   250,194 

Common stock issued for outside consulting services, net of expense

  167,112   2   —   —   136,081   (136,083)  —   — 

Partial repayment of debenture through common stock issuance

  718,744   7   —   —   1,081,684   —   —   1,081,691 

Stock based compensation

  —   —   —   —   932,446   —   —   932,446 

Net loss

  —   —   —   —   —   —   (5,741,583)  (5,741,583)

Balance, September 30, 2026

  17,674,960  $178   973,450  $10  $133,141,562  $(136,083) $(128,954,382) $4,051,285 

 

                  

Additional

         
  

Common Stock

  

Preferred Stock

  

Paid-In

  

Accumulated

  

Stockholders’

 
  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Equity

 

Balance, December 31, 2024

  1,987,262  $20   —  $—  $94,383,917  $(73,461,474) $20,922,463 

Common stock issued from convertible notes conversion

  323,378   3   —   —   1,738,202   —   1,738,205 

Stock based compensation

  —   —   —   —   546,576   —   546,576 

Net loss

  —   —   —   —   —   (14,036,381)  (14,036,381)

Balance, March 31, 2025

  2,310,640  $23   —  $—  $96,668,695  $(87,497,855) $9,170,863 

Common stock issued from convertible notes conversion

  909,418   9   —   —   1,842,797   —   1,842,806 

Stock based compensation

  —   —   —   —   40,479   —   40,479 

Net loss

  —   —   —   —   —   (5,146,737)  (5,146,737)

Balance, June 30, 2025

  3,220,058   32   —   —   98,551,971   (92,644,592)  5,907,411 

Common stock issued from convertible notes conversion

  1,003,045   10   —   —   2,284,982   —   2,284,992 

Fractional shares - Reverse Stock Split

  62   —   —   —   —   —   — 

Stock based compensation

  —   —   —   —   27,252   —   27,252 

Net loss

  —   —   —   —   —   (6,357,557)  (6,357,557)

Balance, September 30, 2025

  4,223,165  $42   —  $—  $100,864,205  $(99,002,149) $1,862,098 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

4

 

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

  

Nine Months Ended

 
  

September 30,

 
  

2026

  

2025

 

Cash flows from operating activities:

        

Net loss

 $(16,365,922) $(25,540,675)

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation and amortization

  820,608   886,904 

Loss on settlement of debt and changes in fair value of debt

  670,452   963,513 

Goodwill impairment charge

  —   10,103,048 

Impairment of intangible assets

  —   3,300,801 

Stock based compensation expense

  2,635,990   614,307 

Deferred income taxes

  (108,151)  — 

Changes in assets and liabilities:

        

Accounts receivable

  —   591,184 

Receivable from related party

  (651,432)  (1,129,007)

Inventory

  —   1,560,698 

Inventory deposits

  —   (2,743,291)

EPA fulfillment asset

  160,511   — 

Prepaid expenses

  47,307   793,465 

Other current assets

  326,001   (93,312)

Other non-current assets and right-of-use assets

  (1,318,011)  (481,795)

Accounts payable

  1,578,715   1,461,854 

EPA contract liability

  (23,625)  — 

Accrued liabilities

  (344,905)  700,039 

Deferred revenue

  —   2,284,415 

Other liabilities

  906,495   432,060 

Net cash used in operating activities

 $(11,665,967) $(6,295,792)

Cash flows from investing activities:

        

Purchase of property and equipment

 $(1,215,115)  (176,828)

Purchase of intangibles

  (2,100)  — 

Azio acquisition, net of cash acquired

  (3,931,149)  — 

Net cash used in investing activities

 $(5,148,364)  (176,828)

Cash flows from financing activities:

        

Proceeds from issuance of common stock

 $2,975,000   — 

Proceeds from issuance of debenture

  13,415,000   — 

Repayment of debentures

  (500,000)  — 

Proceeds from line of credit facility

  1,765,000    

Proceeds from warrants exercised

  7,419   — 

Proceeds from issuance of convertible note

  —   4,750,500 

Proceeds from issuance of other debt

  178,960   — 

Principal repayments on other debt

  (240,647)  (141,466)

Net cash provided by financing activities

 $17,600,732   4,609,034 

Net change in cash

  786,401   (1,863,586)

Cash at the beginning of the period

  358,966   1,941,181 

Cash at the end of the period

 $1,145,367  $77,595 

Supplemental cash flow disclosures:

        

Cash paid for interest expense

 $6,354  $12,037 

Non-cash transfer of inventory deposits to property and equipment

 $—  $1,314,971 

Preferred stock issued - Azio acquisition

 $13,590,900  $— 

Common stock issued - Azio acquisition

 $4,108,787  $— 

Deferred revenue consideration - Azio acquisition

 $4,033,230  $— 

Common stock issued from convertible notes conversion

 $358,658  $5,866,003 

Partial repayment of debenture through common stock issuance

 $1,783,830  $— 

Common stock issued for deferred consulting services

 $136,083  $— 

ROU asset in exchange for operating lease liabilities

 $1,750,797  $611,396 

Deferred outside consulting services

 $136,083  $— 

Warrants issued as financing costs

 $1,385,739  $— 

Warrants issued in conjunction with debentures

 $606,921  $— 

Warrants issued in conjunction with convertible note

 $1,892,068  $— 

 

See Accompanying Notes to Unaudited Consolidated Financial Statements.

 

5

 

AZIO AI HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

 

1.

Organization and Operations

 

Azio AI Holdings Inc. (formerly Envirotech Vehicles, Inc.), including its consolidated subsidiaries ("we," "us," "our," or the "Company"), is a United States ("U.S.") based developer and operator of scalable artificial intelligence ("AI") infrastructure and data center solutions. The Company also has four business segments: (1) electric vehicles, (2) medical supplies, (3) AI data infrastructure, and (4) drones. See Note 14 - Segment Reporting for additional disclosures.

 

On July 2, 2026, the Company acquired Azio AI Corporation (“Legacy Azio") pursuant to the merger of EV-AZ Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“First Merger Sub”) with and into Legacy Azio, pursuant to which Legacy Azio was the surviving corporation and became a wholly owned subsidiary of the Company (the “First Merger”) and immediately following the effective time of the First Merger (the “First Effective Time”), Legacy Azio merged with and into Azio AI, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Second Merger Sub” and, together with the First Merger, the “Mergers”), pursuant to which Second Merger Sub was the surviving entity and became a wholly owned subsidiary of the Company, in accordance with the terms of the Amended and Restated Agreement and Plan of Merger, dated July 2, 2026 (the “Merger Agreement”) and the transactions contemplated thereby, the “Azio Acquisition”)), by and among the Company, Legacy Azio, First Merger Sub and Second Merger Sub. The Azio Acquisition allows the Company to enhance its AI infrastructure business segment to offer the following services:

 
 

●

AI datacenter deployment

 

●

Enterprise graphics processing unit ("GPU") compute

 

●

Digital power infrastructure

 

●

Data center development and digital asset infrastructure

 

 

2.

Summary of Significant Accounting Policies

 

Basis of Presentation—These unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. In the Company’s opinion, these unaudited consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These unaudited consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements for the years ended  December 31, 2025 and 2024 included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Annual Report"). The results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full year.

 

Principles of Consolidation—The accompanying unaudited consolidated financial statements reflect the consolidation of the financial statements of Azio AI Holdings, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.

 

Use of Estimates—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates underlying the Company's unaudited consolidated financial statements include the following: valuation credit expected current losses related on its related party receivables, valuation of the financial instruments and options, discount rate used in estimating its operating lease liabilities, purchase price allocation, ROU assets, evaluation oflong-lived assets impairment and evaluation of goodwill impairment.

 

Out of Period Adjustment—During the three months ended September 30, 2026, the Company identified an error in the measurement of stock-based compensation for stock options granted on May 22, 2026. The expected volatility assumption used to determine the grant-date fair value of the awards incorrectly utilized a mathematical formula rather than what was provided under the relevant authoritative guidance. As a result, stock-based compensation expense and additional paid-in capital were understated by $860,428 for the three and six months ended June 30, 2026.

 

The Company corrected the error in the three months ended September 30, 2026 by recording additional stock-based compensation expense of $860,428, which increased general and administrative expenses and net loss for the period. The correction had no effect on total stockholders' equity, cash, or net cash used in operating activities. Stock-based compensation expense and net loss for the nine months ended September 30, 2026 are presented correctly.

 

Management evaluated the error under SEC Staff Accounting Bulletin No. 99, Materiality, and ASC 250, Accounting Changes and Error Corrections, considering both quantitative and qualitative factors. Management concluded that the error was not material to the previously issued unaudited condensed consolidated financial statements for the three and six months ended June 30, 2026, and that the correction is not expected to be material to the results for the year ending December 31, 2026. Accordingly, the previously issued financial statements have not been revised.

 

6

 

Going Concern—The Company’s unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company sustained significant losses and negative cash flows from operations and is dependent on the overall improvement of its operating activities as well as debt and equity financings to fund its operations. The Company incurred a net loss of $5,741,583 and $16,365,922 for the three and nine months ended September 30, 2026, respectively. Cash used in operating activities was $11,665,967 for the nine months ended September 30, 2026. Accumulated deficit was $128,954,382 as of September 30, 2026. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

 

During the third quarter of 2026, we expanded our operations into the artificial intelligence and data center infrastructure sector through the Azio Acquisition. A significant portion of the capital raised to date and expenditures incurred in connection with these operations has been deployed toward infrastructure, equipment, site development and other expenditures intended to establish the foundation for commissioning and operating revenue-producing AI data center capacity.

 

Management's plans to address the conditions giving rise to substantial doubt include: (i) commissioning and placing into service income-producing data center capacity; (ii) generating revenue from hosting, infrastructure and equipment sales arrangements; (iii) obtaining project-level financing to fund additional data center development and expansion; (iv) raising additional capital through debt or equity financings, as appropriate; and (v) managing operating expenditures as the Company's AI infrastructure operations scale.

 

Future financing proposals, indications of interest and other preliminary commitments may be subject to due diligence, definitive documentation, satisfaction of closing conditions and other contingencies and, unless and until definitive agreements are executed and applicable conditions are satisfied, there can be no assurance that such financing will be consummated on acceptable terms or at all. There can also be no assurance as to the timing of commissioning additional data center capacity, the amount or timing of revenues generated from such capacity, the realization of anticipated benefits from the Azio Acquisition, or the Company's ability to achieve positive operating cash flows.

 

Accordingly, while management believes that its strategic assets, commercial pipeline, financing alternatives and planned commencement and expansion of revenue-generating AI data center operations provide a basis for its plans to improve liquidity and operating results, these plans are not considered probable of being fully implemented within the applicable assessment period to the extent necessary to alleviate the substantial doubt regarding the Company's ability to continue as a going concern.

 

Fair Value of Financial Instruments—The carrying values of the Company’s financial instruments, including cash, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these financial instruments.  Accounting Standards Codification ("ASC") 820, Fair Value Measurements,("ASC 820") defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1:         Observable inputs such as quoted prices in active markets;

 

Level 2:         Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

Level 3:         Unobservable inputs that are supported by little or no market data and that require the reporting entity to develop its own assumptions.

 

The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis other than the debentures, prepaid advances, convertible debt and warrants disclosed in Note 6 - Debt, in which the Company has elected the fair value option for the debentures, prepaid advances and convertible note.

 

Revenue Recognition— The Company recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services and delivery of medical supplies to the customers of its related party. The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers ("ASC 606"), which requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company recorded net revenue of $0 and $0 from the sale of electric vehicles for the three and nine months ended September 30, 2026. The Company recorded net revenue of $0 and $348,063 for the three and nine months ended September 30, 2025, respectively, for the Company's electric vehicles segment. The Company recorded net revenue of $1,872,271 and $6,783,779 for the three and nine months ended September 30, 2026, respectively, for the Company's medical supplies segment. The Company recorded net revenue of $1,812,461 and $3,101,993 for the three and nine months ended September 30, 2025, respectively, for the Company's medical supplies segment. Revenue equal to the accrued labor costs is recorded initially when such costs are incurred. The profit margin is recognized as revenue upon final delivery of medical supplies to a third-party customer. One customer, a related party, accounted for 100% of the net revenue for the three and nine months ended September 30, 2026 for the Company's medical supplies segment.  See Note 10 - Related Party Transactions for further disclosures. The Company recorded net revenue of $0 and $0 for the three months and nine months ended September 30, 2026 for its AI data infrastructure segment, respectively.

 

In applying ASC 606, the Company is required to:

 

 

(1)

identify any contracts with customers;

 

 

(2)

determine if multiple performance obligations exist;

 

 

(3)

determine the transaction price;

 

 

(4)

allocate the transaction price to the respective obligation; and

 

 

(5)

recognize the revenue as the obligation is satisfied.

 

Product revenue primarily includes the sale of electric trucks and cargo vans. These sales represent a single performance obligation and revenue is recognized when the vehicle is delivered, the customer has accepted the vehicle and signed the appropriate documentation acknowledging receipt of the vehicle. At this time, revenue is recognized. Product revenue for the electric vehicles segment for the three and nine months ended September 30, 2026 was $0.

 

Other revenue for the electric vehicles segment for the three and nine months ended September 30, 2026 was $0 and $0, respectively.

 

Medical supply revenue is initially recognized to the extent of incurred labor costs while the profit margin is recognized when the medical supplies are delivered to the third-party customer. The Company acts as the principal and records revenue on a gross basis as it controls the services before transfer to the customer.

 

 

Cash —The recorded value of our cash approximates their fair value. See Concentration of Credit Risk below in this Note.

 

7

 

Accounts Receivable and Allowance for Doubtful Accounts— The accounts receivable balance relates to the Company's electric vehicles segment. The Company had trade accounts receivable of $0 as of  September 30, 2026 and a recorded allowance for expected credit loss of $0, resulting in a net trade accounts receivable balance of $0. The Company had trade accounts receivable of $0 as of  December 31, 2025 and an allowance for expected credit loss of $0, resulting in a net trade receivable balance of $0. 

 

Receivable from Related Party and Allowance for Doubtful Accounts—The receivable from related party relates to the Company's medical supplies segment. The allowance for expected credit loss is established by reviewing several factors, including historical collection experience, current aging of the customer account and financial condition of its customer. The Company had receivable from related party of $1,854,273 and a recorded allowance for expected credit loss of $6,588, resulting in a net receivable from related party of $1,847,685 as of September 30, 2026. The Company had a receivable from related party of $1,202,335 and a recorded allowance for expected credit loss of $6,082, resulting in a net receivable from related party of $1,196,253 as of December 31, 2025.

 

Inventory and Inventory Valuation Allowance—The Company records inventory at the lower of cost or net realizable value, and uses a First In, First Out valuation methodology and establishes an inventory valuation allowance for vehicles that it does not intend to sell in the future or when their cost has fallen below net realizable value. The Company had finished goods inventory on hand of $6,040,410 as of September 30, 2026 and recorded an inventory valuation allowance of $6,040,410 related to vehicles that the Company does not intend to sell in the future, resulting in a net inventory balance of $0 at  September 30, 2026. The Company had finished goods inventory on hand and a related inventory valuation allowance of $6,040,410 and $6,040,410, respectively, as of December 31, 2025, resulting in a net inventory balance of $0 as of December 31, 2025. 

 

EPA Fulfillment Asset—These are costs incurred to fulfill the U.S. Environmental Protection Agency ("EPA") school bus contract that are capitalized. These costs will be expensed to cost of goods sold once all the performance obligations stipulated in the EPA school bus contract are satisfied and revenue from the contract is recognized. The balance of EPA fulfillment asset at September 30, 2026 and  December 31, 2025 was $1,342,966 and $1,503,477, respectively. The Company expects to fulfill the delivery terms of the EPA contract in the future.

 

Other Current Assets—At September 30, 2026, other current assets of $700,615 consist primarily of advances to suppliers.

 

Income Taxes—The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.

 

Accounting for Uncertainty in Income Taxes—The Company evaluates its uncertain tax positions and will recognize a loss contingency when it is probable that a liability has been incurred as of the date of the unaudited financial statements and the amount of the loss can be reasonably estimated. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount recognized. At  September 30, 2026 and December 31, 2025, respectively, management did not identify any uncertain tax positions.

 

Net Loss Per Share—Basic net loss per share is calculated by dividing the Company’s net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period. For the periods presented, the diluted loss per share and basic loss per share calculations are the same as the diluted loss per share calculation would be anti-dilutive.

 

Diluted net loss per share is calculated by dividing the Company’s net loss applicable to common stockholders by the diluted weighted average number of shares of common stock outstanding during the period. The diluted weighted average number of shares of common stock outstanding is the basic weighted number of shares of common stock adjusted for any potentially dilutive debt or equity securities. As of September 30, 2026, 2,051,835 shares of the Company’s common stock were subject to issuance upon the exercise of stock options then outstanding and 2,285,758 shares of the Company’s common stock were subject to issuance upon the exercise of warrants then outstanding.

 

Concentration of Credit Risk—The Company has credit risks related to cash on deposit with a federally insured bank, as at times it exceeds the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (“FDIC”). Additionally, the Company may maintain cash and short-term securities invested at Arvest Bank, National Association (“Arvest”). Between FDIC and the Securities Investor Protection Corporation (“SIPC”) coverage, funds up to $750,000, which may include cash up to $500,000, are insured. In addition, Arvest provides excess insurance acquired by them from SIPC for unlimited per customer securities up to a $1 billion cap. There were no short-term securities invested at Arvest at September 30, 2026. The Company had a concentration in accounts payable, as one vendor made up greater than 71% in the aggregate of the outstanding accounts payable balance as of September 30, 2026. The Company had a concentration in accounts payable, as two vendors made up greater than 10% individually, and approximately 54% in the aggregate of the outstanding accounts payable balance as of December 31, 2025. One customer made up 100% of the receivable from related party.

 

8

 

Impairment of Long-Lived Assets and Other Intangibles—Long-lived assets, including property and equipment, and other intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The Company evaluates these assets to determine potential impairment by comparing the carrying amount to the undiscounted estimated future cash flows of the related assets. If the estimated undiscounted cash flows are less than the carrying value of the assets, the assets are written down to their fair value. There was no impairment of long-lived assets, or property and equipment, for the nine months ended  September 30, 2026. The Company recorded an impairment charge of $3,300,801 for the nine months ended September 30, 2025.

 

Research and Development—Costs incurred in connection with the development of new products and manufacturing methods are charged to operating expenses as incurred. Research and development costs were $12,000 and $34,000 during the three and nine months ended September 30, 2026, respectively. Research and development costs were $43,289 and $731,808 during the three and nine months ended September 30, 2025, respectively.

 

Stock-Based Compensation—The Company accounts for employee stock-based compensation in accordance with the guidance of ASC 718, Stock-Based Compensation, which requires all share-based payments to employees and contractors, including grants of stock options, to be recognized in the unaudited consolidated financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. Non-cash stock-based compensation expenses of $932,446 and $2,635,990 were recorded for the three and nine months ended September 30, 2026, respectively. Non-cash stock-based compensation expense of $27,252 and $614,307 were recorded for the three and nine months ended September 30, 2025, respectively. 

 

Property and Equipment— Property and equipment are stated at cost, less accumulated depreciation. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets, which range from three to five years, except leasehold improvements, which are being amortized over the life of the lease term. Property and equipment qualify for capitalization if the purchase price exceeds $2,000. Major repairs and replacements, which extend the useful lives of equipment, are capitalized and depreciated over the estimated useful lives of the property. All other maintenance and repairs are expensed as incurred. See Note 5 - Property and Equipment, net.

 

EPA Contract Liability—These are amounts related to the EPA school bus program that are expected to be reimbursed to the EPA as a result of the Company's decision to discontinue the electric school bus initiative. The balance of EPA contract liability at September 30, 2026 and  December 31, 2025 was $5,146,066 and $5,169,691, respectively.

 

Leases—The Company accounts for leases in accordance with ASC 842, Leases (“ASC 842”). At the inception or modification of a contract, the Company determines whether a lease exists and classifies its leases as an operating or finance lease at commencement. Right-of-use ("ROU") assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent their obligation to make lease payments arising from the lease. See Note 12 - Leases.

 

As most of the Company’s leases do not provide an implicit interest rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease.

 

The lease asset also reflects any prepaid rent, initial direct costs incurred, and lease incentives received. The Company’s lease terms may include optional extension periods when it is reasonably certain that those options will be exercised.

 

Leases with an initial expected term of 12 months or less are not recorded in the Company's consolidated balance sheets and the related lease expense is recognized on a straight-line basis over the lease term. For certain classes of underlying assets, the Company has elected to not separate fixed lease components from the fixed non-lease components.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

ASU No. 2024-03, “Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses”

 

In November 2024, the Financial Accounting Standards Board issued ASU 2024-03, Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"), which requires additional information about certain expenses in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03 and will adopt the guidance when it becomes effective on a prospective basis.

 

ASU No. 2025-03, "Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is Acquired"

 

In early 2025, the FASB issued ASU 2025-03, “Business Combinations (Topic 805): Determining the Accounting Acquirer When a VIE Is Acquired,” which provides clarifying guidance to help entities identify the accounting acquirer in a business combination when the entity being acquired is a VIE. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

ASU No. 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software"

 

In September 2025, the FASB issued ASU No. 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU simplifies the capitalization guidance by removing all references to prescriptive and sequential software development stages (referred to as “project stages”) throughout ASC 350-40. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. The Company is currently evaluating the provisions of this ASU and does not expect this ASU to have a material impact on the consolidated financial statements.

 

ASU No. 2025-12, "Codification Improvements"

 

In December 2025, the FASB issued ASU No. 2025-12, "Codification Improvements". The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within reporting periods beginning after December 15, 2026, including interim periods within those annual periods. Early adoption is permitted on an issue‑by‑issue basis. The Company is currently evaluating the provisions of this ASU and does not expect this ASU to have a material impact on the consolidated financial statements.

 

 

 

3.

Acquisition

 

On July 2, 2026, the Company completed the Azio Acquisition, pursuant to the Merger Agreement, by and among (i) Legacy Azio AI, (ii) the Company, (iii) First Merger Sub, and (iv) the Second Merger Sub.

 

Pursuant to the Merger Agreement, (i) First Merger Sub merged with and into Legacy Azio in the First Merger, pursuant to which Legacy Azio was the surviving corporation and became a wholly owned subsidiary of the Company and (ii) immediately following First Effective Time, the surviving corporation of the First Merger merged with and into Second Merger Sub in the Second Merger, pursuant to which Second Merger Sub was the surviving entity (the “Surviving Entity”) and became a wholly owned subsidiary of the Company such effective time of the Second Merger, the “Second Effective Time”).

 

Under the terms of the Merger Agreement, in connection with the closing of the transactions contemplated by the Merger Agreement (the “Closing”) and as of the First Effective Time, the Company issued to the holders of shares of Legacy Azio AI common stock issued and outstanding immediately prior to the First Effective Time (the “Legacy Azio Stockholders”) (other than shares held in treasury or held by Legacy Azio AI) (i) 2,460,351 shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), which such number of shares represented a number of shares equal to no more than (a) 19.9% (the “Exchange Cap”) of the outstanding shares of Common Stock immediately prior to the First Effective Time, minus (b) 194,807 shares of Common Stock issuable upon conversion of the $150,000 aggregate principal amount of outstanding convertible notes of Legacy Azio  being assumed by the Company as of the Closing (the “Convertible Notes”), and (ii) 973,450 shares of the Company’s Series A Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”) (such aggregate shares in (i) and (ii) collectively, the “Merger Consideration”).

 

The Convertible Notes remained outstanding after the First Effective Time and, thereafter, will be convertible into shares of Common Stock.

 

No fractional shares of Common Stock and Series A Preferred Stock were issued in connection with the First Merger. Any fractional shares that a Legacy Azio AI Stockholder would otherwise be entitled to receive were aggregated and any remaining fractional shares were rounded up to the nearest whole share.

 

Each share of Series A Preferred Stock will be convertible into 100 shares of Common Stock upon approval by the Company’s stockholders. If such shares were converted, the Legacy Azio Stockholders would hold approximately 85% of the shares of the Company. The Series A Preferred Stock is non-voting at the time of acquisition.

 

Identification of the Accounting Acquirer

 

The Company evaluated the Mergers under ASC 805-10-55-11 through 55-15 to determine the accounting acquirer. The Company (formerly Envirotech Vehicles, Inc.) is the legal acquirer, remained the Nasdaq-listed SEC registrant, and issued its equity interests as the Merger Consideration: 2,460,351 shares of Common Stock, limited by the 19.9% Exchange Cap, and 973,450 shares of Series A Preferred Stock. Legacy Azio AI, which was incorporated on October 7, 2025, is the legal acquiree. Because a significant portion of the Merger Consideration was issued in the form of non-voting convertible preferred stock, management considered all of the factors below, and not only the legal form of the transaction, in determining the accounting acquirer.

 

 

●

Relative voting rights. Immediately following the Closing, the Legacy Azio AI Stockholders held approximately 14.4% of the outstanding shares of Common Stock, and the Company's pre-Closing stockholders, including holders of vested and exercisable warrants, held approximately 85.6%. The Series A Preferred Stock has no voting rights, including in the election of directors, except for limited protective provisions and as required by Delaware law. It is not convertible until the Company's stockholders approve the conversion under Nasdaq Listing Rule 5635, and conversion is subject to beneficial ownership limitations. If fully converted, the Series A Preferred Stock would be convertible into 97,345,000 shares of Common Stock. The Company concluded that stockholder approval of the conversion is a substantive event outside the Company's control. The officers and directors who agreed in support agreements entered into at the Closing to vote in favor of the conversion held approximately 1.9% of the outstanding Common Stock immediately before the Closing and cannot approve the conversion unilaterally. The Legacy Azio AI Stockholders are not entitled to vote their shares received in the Mergers on the conversion. On November 13, 2026, the vote on the conversion was adjourned to December 4, 2026, pending Nasdaq's approval of the Company's initial listing application under Nasdaq Listing Rule 5110(a). Accordingly, the Company's pre-Closing stockholders retained a substantial majority of the voting rights after the Closing.

 

●

Large minority voting interest. No single Legacy Azio AI Stockholder obtained a large minority voting interest. As of September 10, 2026, the largest former Legacy Azio AI holder among the Company's directors and officers, Accel Venture III LLC (whose sole member is the Company's Chief Executive Officer), beneficially owned approximately 2.9% of the outstanding Common Stock. The 194,690 shares of Series A Preferred Stock that it holds are non-voting.

 

●

Composition of the governing body. Under the Merger Agreement, Legacy Azio AI was entitled to appoint one director. Immediately before the Closing, the Board consisted of four incumbent directors. At the Closing, Phillip W. Oldridge resigned as Chairman and director, and Chris Young, Legacy Azio AI's designee, was appointed as a Class II director. Immediately following the Closing, a majority of the Board therefore consisted of incumbent directors: Jason Maddox, Michael A. Di Pietro and Terri White Elk. On September 8, 2026, the Board appointed Larry G. Paige II as an independent Class III director to fill an existing vacancy. The Company's stockholders, whose voting power is held predominantly by the Company's pre-Closing stockholders, retain the authority to elect and remove directors.

 

●

Composition of senior management. At the Closing, Chris Young, Legacy Azio AI's Chief Executive Officer, was appointed Chief Executive Officer of the Company, replacing the Company's existing Chief Executive Officer. Effective August 27, 2026, the Board removed the four other former Legacy Azio AI officers appointed at the Closing (Simon Yu, President; David Shiue, Chief Business Development Officer; Gary Chen, Chief Product Officer; and Jenny Yang, Chief Administrative Officer) as executive officers of the Company, pending stockholder approval and approval of the Company's Nasdaq initial listing application. On August 28, 2026, Nasdaq notified the Company that this action had remediated the deficiency it had identified under Nasdaq Listing Rule 5635(b), and that the matter was closed. As a result, Mr. Young is the only former Legacy Azio AI executive serving as an executive officer of the Company. The Company's pre-Closing executives, Jason Maddox (Chief Financial Officer) and Elgin Tracy (Chief Operating Officer), continue in their roles.

 

●

Relative size. The Company is significantly larger than Legacy Azio AI. For the six months ended June 30, 2026, the Company reported approximately $15.6 million of total assets and $4.9 million of revenue, compared with approximately $0.7 million of total assets and $0.2 million of revenue for Legacy Azio AI. For the year ended December 31, 2025, the Company reported approximately $5.9 million of revenue. Legacy Azio AI reported no revenue for the period from October 7, 2025 (inception) through December 31, 2025.

 

●

Issuer of equity and initiation of the combination. The Company issued its equity interests to effect the combination, and its Board approved the Merger Agreement after evaluating strategic alternatives. The Company (Envirotech Vehicles, Inc.) initiated the combination, which led to the non-binding letter of intent entered into on December 16, 2025.

 

Based on the weight of these factors, in particular the relative voting rights and the composition of the Board immediately following the Closing, and the Company's significantly greater relative size, the Company concluded that it is the accounting acquirer. The Mergers were accounted for as a business combination under the acquisition method in accordance with ASC 805, rather than as a reverse acquisition. Accordingly, Legacy Azio AI's identifiable assets acquired and liabilities assumed were recognized at their preliminary estimated fair values as of July 2, 2026, the acquisition date. Legacy Azio AI's results of operations are included in the Company's consolidated financial statements from that date. The Company's historical financial statements for periods before the Closing are those of the Company, formerly Envirotech Vehicles, Inc., and have not been retroactively adjusted to reflect the historical financial position or results of operations of Legacy Azio AI.

 

Preliminary Purchase Price Allocation

 

The Company recorded the assets acquired and liabilities assumed as of the date of the Closing based on the information available at that date.

 

Consideration

    

Common stock consideration

 $4,108,787 

Preferred stock consideration

  13,590,900 

Deferred revenue representing a deposit paid by the Company

  4,033,230 

Fair value of total consideration transferred

 $21,732,917 
     

Recognized amounts of identifiable assets acquired and liabilities assumed

    

Cash

  102,081 

Inventory

  291,248 

Intangible assets

  19,010,000 

Other current assets

  232,500 

Prepaid expenses

  40,000 

Accounts payable

  (103,492)

Deferred tax liability

  (3,992,100)

Loan from related party

  (100,000)

Other current liabilities

  (1,049)

Convertible Notes

  (249,602)

Total identifiable net assets

  15,229,586 
     

Goodwill

  6,503,331 

 

 

Working capital accounts were valued at their respective carrying amounts because the Company believes that these amounts approximate the current fair values. The preliminary estimate of the fair value of the identifiable intangible assets (customer contract and supplier relationship) was determined by the Company with the assistance of a third-party valuation expert.

 

The customer contract was preliminarily valued using the income approach, specifically the multi-period excess earnings method. The valuation was based on projected cash flows expected to be generated from the acquired customer agreement. Significant assumptions utilized in the valuation included projected contracted capacity deployment, expected revenue and operating margins, and a discount rate of approximately 29%. The customer contract intangible asset was assigned an estimated useful life of approximately 10 years based on the period over which the underlying contract is expected to generate economic benefits.

 

Supplier relationships were preliminarily valued using the income approach, specifically the with-and-without method. The valuation reflects the economic benefits derived from established relationships and reseller authorizations with key hardware suppliers that provide access to GPU servers and related AI infrastructure products. Significant assumptions utilized in the valuation included projected hardware distribution revenues, expected reseller margins, the anticipated decline in benefits from the existing supplier base over time, and a discount rate of approximately 32%. The supplier relationship intangible asset was assigned an estimated useful life of approximately five years based on the expected duration of the economic benefits associated with these relationships.

 

The above allocation of the purchase price is based upon certain valuations and other analyses that have not been completed as of the date of this filing. Any changes in the estimated fair values of the net assets recorded for the Azio Acquisition upon the finalization of more detailed analyses of the facts and circumstances that existed at the date of the Closing will change the allocation of the purchase price. As such, the purchase price allocation for the Azio Acquisition is a preliminary estimate, which is subject to change within the measurement period. Any increase or decrease in the fair value of Legacy Azio Acquisition tangible and identifiable intangible assets and liabilities as compared with the information shown herein would also change the portion of the purchase price allocable to goodwill.

 

The goodwill recorded related to the Azio Acquisition is the excess of the fair value of consideration transferred by the Company over the fair value of the net identifiable assets and liabilities assumed at the date of the Closing.

 

The following table discloses certain unaudited financial information. Since Legacy Azio AI (acquiree) was formed in the fourth quarter of 2025, no financial information is presented for the comparative periods in 2025. No financial information is also presented for the three months ended September 30, 2026 as the actual unaudited financial results presented elsewhere in this filing incorporates such unaudited information.

 

  

Nine months ended

 
  

September 30, 2026

 

Sales, net

 $6,783,779 

Net loss

 $(21,741,375)

 

 

4.

Other Intangible Assets

 

  

As of September 30, 2026

 
                     
  

Gross carrying amount

  

Accumulated amortization

  

Net amount

  

Original useful life

  

Weighted average amortization period (in years)

 

Intangible assets:

                    

Customer contracts

 $16,899,000  $(412,058) $16,486,942   10.00   9.75 

Supplier relationships

  2,111,000   (102,947)  2,008,053   5.00   4.75 

Trade names and trademarks

  2,100   -   2,100   1.00   1.00 

Intangible assets, net

 $19,012,100  $(515,005) $18,497,095         

 

  

Amortization expense

 

Remainder of 2026

 $528,130 

2027

 $2,112,100 

2028

 $2,112,100 

2029

 $2,112,100 

2030 and beyond

 $11,632,665 
  $18,497,095 

 

Amortization expense was $515,005 and $515,005 for the three and nine months ended September 30, 2026, respectively.

 

 

5.

Property and Equipment, Net

 

Components of property and equipment, net, consist of the following as of  September 30, 2026 and December 31, 2025:

 

      

September 30,

  

December 31,

 
  

Useful life (in years)

  

2026

  

2025

 

Furniture and fixtures

  5  $125,620  $125,620 

Leasehold improvements

  Various   810,885   380,286 

Machinery and equipment

  5   377,521   377,521 

Vehicles

  5   417,693   387,693 

Construction in progress

  N/A   754,516   — 

Test/Demo vehicles

  5   30,685   30,685 

Total property and equipment

      2,516,920   1,301,805 

Less accumulated depreciation

      (1,131,449)  (825,846)

Property and equipment, net

     $1,385,471  $475,959 

 

Depreciation expense was $188,521 and $105,150 for the three months ended September 30, 2026 and 2025, respectively. Depreciation expense was $305,603 and $219,404 for the nine months ended September 30, 2026 and 2025, respectively. 

 

9

    
 

6.

Debt

 

Notes Payable

 

On August 28, 2025, the Company entered into a premium financing agreement with AFCO Insurance Premium Finance to finance certain insurance coverages other than its directors' and officers' insurance coverages. The $114,140 loan is payable over eleven months, beginning in September 2025, and bears interest at 8.24% with monthly payments of $7,809 and an initial down payment of $39,515. The balance of this note, including accrued interest, was $46,457 as of September 30, 2026.

 

On January 1, 2026, the Company entered into a premium financing agreement with IPFS Corporation to finance certain insurance coverages. The $79,303 loan is payable over 11 months, beginning in February 2026, and bears interest at 7.90% with monthly payments of $7,214 and an initial down payment of $25,435. The balance of this note was $6,695 as of  September 30, 2026.

 

The Company has remaining miscellaneous notes payable of $30,459 at September 30, 2026. 

 

Amended and Restated Standby Equity Purchase Agreement (the "A&R SEPA")

 

On  October 31, 2024, the Company entered into A&R SEPA with YA II PN, Ltd. (the "Investor"). The A&R SEPA amends and restates in its entirety the standby equity purchase agreement, dated  September 23, 2024, by and between the Company and the Investor (the “Original SEPA”).

 

Pursuant to the A&R SEPA, except for so long as there is a balance outstanding under the Promissory Notes (as defined below) and the Additional Promissory Notes (as defined below), the Company has the right, from time to time, until  November 1, 2027, to require the Investor to purchase up to $25 million of shares of common stock, subject to certain limitations and conditions set forth in the A&R SEPA, by delivering written notice to the Investor. Pursuant to the A&R SEPA, the Investor advanced to the Company the principal amount of $3 million (the “Pre-Paid Advance”) in exchange for the Company’s issuance to the Investor of convertible promissory notes (the “Promissory Notes”) in two tranches, resulting in net proceeds (net of discounts and fees) to the Company of $2,635,500. The Company received the first tranche of the Pre-Paid Advance in the principal amount of $2 million on  October 31, 2024 in exchange for the Promissory Note dated  October 31, 2024 (the “EVTV-1 Promissory Note”), and the second tranche of the Pre-Paid Advance in the principal amount of $1 million on  December 17, 2024 in exchange for the Promissory Note dated  December 17, 2024 (the “EVTV-2 Promissory Note”). The Promissory Notes accrue interest on the outstanding principal balance at an annual rate equal to 0%, which would increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Promissory Notes) or a Registration Event (as defined in the Promissory Notes) for so long as such event of default remained uncured. Prior to the Company’s entry into the Supplemental Agreement (as defined below), the Promissory Notes were initially set to mature on  November 13, 2025 and were convertible at a conversion price equal to the lower of (i) $21.48 per share or (ii) 93% of the lowest daily volume weighted average price of the Company’s common stock on Nasdaq Stock Market LLC (“Nasdaq”) as reported by Bloomberg L.P. (“VWAP”) during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which was $3.58 per share, subject to adjustment from time to time in accordance with the terms contained in the Promissory Notes). Pursuant to the terms of the Original SEPA, the Company issued 6,410 shares of common stock to the Investor as a commitment fee.

 

During 2025, the obligation under the EVTV-1 Promissory Note was partially satisfied through the conversion of the EVTV-1 Promissory Note into shares of the Company's common stock. As a result of this conversion, 1,416,116 shares of the Company's common stock were issued at a weighted average price of $1.06. The remaining principal balance of the EVTV-1 Promissory Note at  December 31, 2025, was $285,000. The remaining obligation was fully satisfied through the conversion of the EVTV-1 Promissory Note into shares of the Company's common stock during the first quarter of 2026. As a result of this conversion, 529,096 shares of the Company's common stock were issued at a weighted average price of $0.63.

 

The Company has elected to measure the Promissory Notes at fair value. In estimating the fair value of the Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the common stock. The Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. All debt obligations related to the Promissory Notes have been repaid in full at June 30, 2026.

 

Supplemental Agreement to A&R SEPA

 

On  February 24, 2025, the Company entered into a supplemental agreement, dated  February 24, 2025 (the “Supplemental Agreement”), with the Investor, which amends and supplements the A&R SEPA to: (i) provide for the advancement by the Investor to the Company, subject to the satisfaction of certain conditions as set forth in the Supplemental Agreement, of $5 million under the A&R SEPA (the “Additional Pre-Paid Advance”), to be evidenced by convertible promissory notes (the “Additional Promissory Notes”) in two tranches, (ii) amend the maturity date for the EVTV-1 Promissory Note to  March 9, 2026, and (iii) amend the floor price for the EVTV-1 Promissory Note to $0.7130 per share.

 

The Additional Promissory Notes accrue interest on the outstanding principal balance at an annual rate equal to 5%, which would increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Additional Promissory Notes) or a Registration Event (as defined in the Additional Promissory Notes) for so long as such event remained uncured. The Additional Promissory Notes were scheduled to mature on  March 9, 2026. The Additional Promissory Notes were convertible at a conversion price equal to the lower of (i) $10.00 per share or (ii) 93% of the lowest daily VWAP during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $0.7130 per share, subject to adjustment from time to time in accordance with the terms contained in the Additional Promissory Notes).

 

The first tranche of the Additional Pre-Paid Advance was disbursed on  February 25, 2025 in the principal amount of $3 million (with net proceeds to the Company of approximately $2.7 million after deducting discounts and fees) as evidenced by an Additional Promissory Note issued by the Company to the Investor on  February 24, 2025 (the “EVTV-3 Additional Promissory Note”). During 2025, the obligation under the EVTV-3 Additional Promissory Note in the principal amount of $3 million was partially satisfied through the conversion of the EVTV-3 Additional Promissory Note into shares of the Company's common stock. As a result of this conversion, 2,134,613 shares of the Company's common stock were issued at a weighted average price of $1.51. The remaining principal balance of the EVTV-3 Additional Promissory Note on  December 31, 2025, was $50,000. The remaining obligation was fully satisfied through the conversion of the EVTV-3 Additional Promissory Note into shares of the Company's common stock during the first quarter of 2026. As a result of this conversion, 94,657 shares of the Company's common stock were issued at a weighted average price of $0.53.

 

The Company has elected to measure the Additional Promissory Notes at fair value. In estimating the fair value of the Additional Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the Company's common stock. The Additional Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. All debt obligations related to the Additional Promissory Notes have been repaid in full at June 30, 2026.

 

Standby Equity Purchase Agreement 

 

On September 25, 2026, the Company entered into a standby equity purchase agreement (the “SEPA”) with the Investor. Pursuant to the SEPA, the Investor will advance to the Company, subject to the satisfaction of certain conditions, an aggregate principal amount of $3.5 million (the “Azio Pre-Paid Advance”), which shall be evidenced by convertible promissory notes in two tranches (the "Azio Promissory Notes"). The Azio Promissory Notes will accrue interest at an annual rate equal to 6%, which shall increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Azio Promissory Notes) for so long as such event remains uncured. The Azio Promissory Notes will mature on September 25, 2027, which may be extended at the option of the Investor. The Investor has the right to convert into shares of Common Stock (i) in the case of a Payment Failure (as defined in the Azio Promissory Notes), all or part of the applicable Monthly Payment Amount (as defined in the Azio Promissory Notes) at any time after such Payment Failure has occurred into shares of Common Stock or (ii) in the case of an Event of Default (as defined in the Azio Promissory Notes), if such Event of Default has not been cured or waived in writing by the Investor, all or part of the Azio Promissory Note at any time after the occurrence of an Event of Default and so long as the applicable Event of Default is continuing, in each case, at a conversion price equal to 92% of the lowest daily VWAP during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $0.26 per share, subject to adjustment from time to time in accordance with the terms contained in the Azio Promissory Notes).

 

The first tranche of the Azio Pre-Paid Advance was disbursed on September 25, 2026, in the principal amount of $3.0 million (with net proceeds of approximately $2.2 million to the Company after deducting for discount and fees). The second tranche of the Azio Pre-Paid Advance will be in the principal amount of $0.5 million and advanced on the second trading day after the SEPA Resale Registration Statement (as defined below) first becomes effective. At the closing of each Pre-Paid Advance, the Investor will advance to the Company the principal amount of the applicable tranche of the Pre-Paid Advance, less a discount in the amount equal to 4% of the principal amount of such tranche of the Pre-Paid Advance netted from the purchase price due and structured as an original issue discount.

 

Pursuant to the SEPA, and upon the satisfaction of the conditions to the Investor’s purchase obligation set forth in the SEPA the Company will have the right, from time to time, until termination or expiration of the SEPA, to require the Investor to purchase up to $50 million (the “Commitment Amount”) of shares of Common Stock, subject to certain limitations and conditions set forth in the SEPA, by delivering written notice to the Investor (“Advance Notice” and the issuance and sale of such shares as specified therein, an “Advance”). The Company may, in its sole discretion, select the amount of the Advance that the Company desires to issue and sell to the Investor in each Advance Notice, subject to a maximum limit equal to 100% of the average of the daily volume traded of the Common Stock on the Nasdaq Capital Market for the five consecutive trading days immediately preceding the delivery of an Advance Notice (the “Maximum Advance Amount”).

 

For so long as any amount remains outstanding under the Promissory Notes or under the debentures issued by the Company to the Investor pursuant to the securities purchase agreement, dated as of March 6, 2026, by and between the Company and the Investor (the Debentures), the Company may only, except with the prior written consent of the Investor, submit an Advance Notice if the aggregate purchase price owed to the Company from such Advances (the “Advance Proceeds”) shall be paid by the Investor by offsetting the amount of the Advance Proceeds against an equal amount outstanding under the subject Promissory Note or Debentures (applied first towards accrued and unpaid interest, and then towards outstanding principal).

 

The shares of Common Stock to be purchased pursuant to an Advance Notice will be issued and sold to the Investor at a per share price equal to, at the Company’s election as specified in the relevant Advance Notice: (i) 96% of the Market Price (as defined below) for any period commencing upon the receipt of the Advance Notice by the Investor and ending at 4:00 p.m., Eastern Time, on the same trading day, unless otherwise agreed by the parties (the “Option 1 Pricing Period”), or (ii) 97% of the Market Price for the three consecutive trading days commencing on the day such Advance Notice is delivered (the “Option 2 Pricing Period,” and each of the Option 1 Pricing Period and the Option 2 Pricing Period, a “Pricing Period”). “Market Price” is defined as, for any Option 1 Pricing Period, the daily volume weighted average price of the Common Stock on the Nasdaq Capital Market as reported by Bloomberg L.P. (“VWAP”) during the Option 1 Pricing Period, and for any Option 2 Pricing Period, the lowest daily VWAP of the Common Stock during the Option 2 Pricing Period.

 

If, with respect to an Option 1 Pricing Period, the total number of shares of Common Stock traded on the Nasdaq Capital Market during the applicable Pricing Period is less than the Volume Threshold (as defined below), then the number of shares of Common Stock issued and sold pursuant to such Advance Notice will be reduced to the greater of (i) 30% of the trading volume of the Common Stock on the Nasdaq Capital Market during the relevant Pricing Period as reported by Bloomberg L.P. or (ii) the number of shares of Common Stock sold by the Investor during such Pricing Period, but in each case not to exceed the amount requested in the Advance Notice. “Volume Threshold” is defined as a number of shares of Common Stock equal to the quotient of (i) the number of shares requested by the Company in the Advance Notice divided by (ii) 0.30.

 

As consideration for its commitment to purchase shares of Common Stock at the Company’s request under the SEPA, the Company issued to the Investor, upon execution of the SEPA, warrants exercisable for the purchase of an aggregate of 1,735,758 shares of Common Stock (the “ SEPA Warrants” and the shares of Common Stock underlying such SEPA Warrants, the “Commitment Shares”) at an exercise price of $0.01 per share. In addition, the Company paid a structuring fee to the Investor in an aggregate amount of $50,000 which was paid from a portion of the proceeds of the initial Azio Pre-Paid Advance.

 

The SEPA will automatically terminate on the earliest to occur of (i) September 25, 2029, subject to delay until the Promissory Notes and the Debentures have been repaid in full, or (ii) the date on which the Investor shall have purchased from the Company under the SEPA the Commitment Amount in full. The Company may terminate the SEPA at any time upon five trading days’ prior written notice to the Investor, provided that there are no outstanding Advance Notices under which the Company is yet to issue Common Stock and provided that the Company has paid all amounts owed to the Investor pursuant to the SEPA and the Azio Promissory Notes. The Company and the Investor may also agree to terminate the SEPA by mutual written consent. Neither the Company nor the Investor may assign or transfer their respective rights and obligations under the SEPA, and no provision of the SEPA may be modified or waived by the Company or the Investor other than by an instrument in writing signed by both parties. The principal amount at September 30, 2026 is $3,000,000 and the book value is $1,002,396.

 

Registration Rights Agreement

 

In connection with the SEPA, the Company and the Investor entered into a registration rights agreement, dated as of September 25, 2026 (the “Registration Rights Agreement”), pursuant to which the Company agreed to file a registration statement on Form S-3 (or, if the Company is not then eligible, on Form S-1) covering the resale by the Investor of up to 28,000,000 shares of Common Stock issuable pursuant to Advances under the SEPA and the Commitment Shares (the “SEPA Resale Registration Statement”) in accordance with applicable U.S. Securities and Exchange Commission (the “SEC”) rules, within 30 days of the date of the Registration Rights Agreement, and use its best efforts to have the SEPA Resale Registration Statement declared effective by the SEC as soon as practicable but no later than the 60th calendar day following the filing thereof (or the 120th calendar day if the Company is informed by the SEC staff that the staff will review the SEPA Resale Registration Statement); provided that in the event the Company is notified by the SEC that the SEPA Resale Registration Statement will not be reviewed or is no longer subject to further review and comments, the deadline shall be the fifth business day following the date on which the Company is so notified if such date is earlier than the deadline specified above.

 

The Company has elected to measure the Azio Pre-paid Advance at fair value. In estimating the fair value of the Azio Pre-paid Advance, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the Company's common stock. The Azio Pre-paid Advance's fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. Net proceeds of 2,166,900 received in the third quarter of 2026 were allocated to the Azio Pre-paid Advance and Warrants based on their relative fair values. The Azio Pre-paid Advance is classified as Short-term Notes Payable and the Warrants which were equity classified on the Company's unaudited condensed consolidated balance sheets. The Company elected the fair value option for the Azio Prepaid Advance and as a result, recorded an unrealized gain/loss of $14,464 and $14,464 for the three and nine months ended September 30, 2026, respectively, on the Company's unaudited consolidated income statements.

 

Debenture Financing

 

On  March 6, 2026, the Company entered into a securities purchase agreement (the “SPA”) with the Investor, pursuant to which the Company agreed to issue and sell to the Investor, and the Investor agreed to purchase, the Debentures in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches with the purchase price of the Debentures in each tranche being equal to 96% of the Subscription Amount to be purchased. The closing of the initial tranche of Debentures occurred on  March 6, 2026 (the “First Closing”), in which the Company issued Debentures in the aggregate principal amount of $4,000,000 (the “First Closing Debentures”) to the Investor. Pursuant to the SPA, the Company and the Investor have agreed that the closing of the second tranche of the remaining $7,000,000 in aggregate principal amount of the Debentures (the “Second Closing” and such Debentures, the “Second Closing Debentures”) will occur on or before the first business day after the Company’s filing of the registration statement with the SEC registering the resale of the shares of the Company’s common stock issuable upon exercise of the Debenture Warrants (as defined below) and no less than 10,000,000 shares of the Company’s common stock issuable pursuant to the A&R SEPA (such registration statement, the “Debenture Resale Registration Statement”), has been declared effective and subject to the satisfaction or waiver of customary closing conditions set forth in the SPA. The sale of the Debentures to the Investor resulted in gross proceeds to us of approximately $10,535,000, after deducting a one-time due diligence and structuring fee to the Investor of $25,000 but before deducting any other fees and expenses.

 

In addition, in connection with the First Closing, as a commitment fee for the transactions contemplated by the SPA, the Company issued to the Investor warrants to purchase up to 1,291,778 shares of the Company’s common stock at an exercise price of $0.01 per share (the “Debenture Warrants”). The Debenture Warrants are immediately exercisable and will expire 60 months from the date of issuance. The Debenture Warrants include customary adjustment provisions for stock splits, combinations and similar events.

 

The Debentures bear interest at a rate of 5.0% per annum, subject to a potential increase to 18.0% per annum upon the occurrence of certain events of default. The Debentures mature on  March 6, 2027 (the “Maturity Date”). The Company will repay the outstanding principal of the Debentures in monthly installments of (i) $363,636 for the First Closing Debentures and (ii) $636,364 for the Second Closing Debentures, in each case, plus accrued and unpaid interest, in cash, beginning on the 30th calendar day following the effectiveness of the Debenture Resale Registration Statement, with all remaining outstanding principal plus accrued and unpaid interest due in full on the Maturity Date. Any outstanding principal amount of, and accrued and unpaid interest on, the Debentures as of the Maturity Date will be due and payable on the Maturity Date.

 

The Debentures provide the Company with an optional redemption right pursuant to which we, at any time,  may redeem in cash, in whole or in part, all amounts outstanding under the Debentures prior to the Maturity Date. The redemption amount shall be equal to the outstanding principal balance of the Debentures being redeemed by the Company, plus all accrued and unpaid interest thereon as of such redemption date.

 

Net proceeds of $3,815,000 received in the First Closing were allocated to the Debentures and Debenture Warrants based on their relative fair values on the First Closing. The Debentures are classified as Short-term Notes Payable and the Debenture Warrants which were equity classified on the Company's unaudited consolidated balance sheets. The Second Closing occurred on May 6, 2026 and net proceeds of $5,850,000 were received (net of commission expense of $870,000 and discount of $280,000). The Company elected the fair value option for the Debentures and as a result, recorded an unrealized gain of $417,302 for the three months ended September 30, 2026 and an unrealized loss of $449,673 for the nine months ended September 30, 2026 on the Company's unaudited consolidated income statements.

 

During the second and third quarter of 2026, partial repayments either through conversion of Azio's common stock or cash refinancing of the Debenture related to the Second Closing were made. The principal balance after these repayments at September 30, 2026 is $8,809,267 and the fair value is $7,204,856.

 

Line of Credit Facility

 

On October 21, 2026 (the “Effective Date”), the Company entered into a Revolving Credit Facility Agreement (the “Credit Agreement”) with Azio Corporation, a California corporation (the “Lender”), providing for an unsecured revolving credit facility (the "Credit Facility") of up to $2,300,000 (the “Loan Commitment”), inclusive of the Prior Advances (as defined below). Pursuant to the Credit Agreement, the Company may, from time to time, request loans (each, a “Loan” and collectively, “Loans”) from the Lender, up to the Loan Commitment. The Lender may, in its sole discretion, fund any Loan that would cause the aggregate principal balance of the Loans to exceed the Loan Commitment upon its prior written consent. Amounts borrowed under the Credit Agreement shall be evidenced by an unsecured revolving promissory note (the “Promissory Note”) executed by the Company and payable to the order of the Lender. Prior to entering into the Credit Agreement, the Lender provided the Company amounts totaling $2,225,000 (the “Prior Advances”). Pursuant to the Credit Agreement, the Company and the Lender agreed that the Prior Advances shall be deemed Loans and subject to the terms and conditions thereunder as of the Effective Date. Proceeds from the Credit Agreement may be used for working capital for the Company and such other uses as determined by the Board of Directors of the Company.

 

The Credit Agreement will mature on the first business day following the one-year anniversary of the Effective Date (the “Credit Facility Maturity Date”), and all outstanding Loans, plus all accrued and unpaid interest thereon, shall be due and payable on such date. Prior to the Credit Facility Maturity Date, all outstanding Loans may be prepaid by the Company, in its sole discretion, in whole or in part, to the Lender, and may thereafter be borrowed or reborrowed, subject to the terms of the Credit Agreement. All such prepayments shall be allocated first to accrued and unpaid interest, and thereafter to reduce the principal amount then owing.

 

The Revolving Promissory Note will bear interest at the rate of 8.5% per annum, which shall be calculated on the basis of a year consisting of 365 days or 366 days, as applicable. No payments of interest or principal amount as to any Loan will be due prior to the Credit Maturity Date. The Credit Agreement contains customary events of default. If an event of default has occurred and continues after any applicable grace period, the Lender may, by notice to the Company, declare all outstanding Loans, plus all accrued and unpaid interest thereon, due and payable, except that acceleration will be automatic in the case of bankruptcy and insolvency events of default involving the Company.

 

The Company, in its sole discretion, may terminate the Credit Agreement at any time, for any reason, by giving the Lender not less than three days’ written notice. Such termination only takes effect once the Company has repaid all outstanding Loans, plus all accrued and unpaid interest thereon, in full. The Lender, in its sole discretion, may terminate the Credit Agreement by delivering to the Company not less than 30 days’ written notice prior to the effective date of such termination (the “Notice Period”). During the Notice Period, the Lender will keep funding Loans to the Company under the Credit Agreement and interest will continue to accrue on the outstanding indebtedness under the Credit Agreement through and including the effective date of termination. On the effective date of termination, all outstanding Loans, plus all accrued and unpaid interest thereon, will be due and payable in full.

 

Each of the Credit Agreement and the Revolving Promissory Note contains customary representations, warranties and conditions of the parties thereto. The representations, warranties and covenants contained in each of the Credit Agreement and the Revolving Promissory Note were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the parties.

 

Chi Wei David Shiue, the former Chief Business Development Officer of the Company and the sole member of Alora LLC, a beneficial owner of more than five percent (5%) of the outstanding shares of the Company’s common stock, is the Chief Executive Officer and President and a majority shareholder of the Lender. See also Note 10 - Related Party Transactions. The balance of the Credit Facility at September 30, 2026 is $1,765,000. The credit facility agreement was entered into in October 2026. See Note 15 - Subsequent Events for further disclosures.

 

Debt - Long-term

 

February 2026 Convertible Note

 

On February 12, 2026, the Legacy Azio entered into a Note Purchase Agreement with Pegasus Technology LLC (“Pegasus”), pursuant to which Legacy Azio issued and sold to Pegasus a convertible promissory note in the principal amount of $100,000 (the “February 2026 Convertible Note”) for a purchase price of $100,000. The proceeds from the issuance of the February 2026 Convertible Note were used for general working capital purposes. This note was assumed by the Company in the Azio Acquisition disclosed in Note 3 - Acquisition.

 

The February 2026 Convertible Note bears interest at 5% per annum, calculated on a simple, non-compounding basis, and matures on February 12, 2031, the fifth anniversary of the issuance date, unless earlier converted or prepaid in accordance with its terms. No payments of principal or interest are required prior to maturity, other than as specifically provided in the February 2026 Convertible Note. The Company may prepay all or any portion of the outstanding indebtedness at any time in cash prior to maturity.

 

Upon the occurrence of a Trigger Event, defined in the February 2026 Convertible Note as the occurrence of an initial public offering (“IPO”) of the Company’s common stock or a reverse takeover (“RTO”) transaction involving the Company, whichever is first, the February 2026 Convertible Note may be converted, in whole or in part, only beginning on the sixth trading day following such Trigger Event. In the event of an IPO, the February 2026 Convertible Note is convertible into shares of the Company’s common stock. In the event of an RTO or similar transaction, the February 2026 Convertible Note is convertible into shares of common stock of the acquirer, successor, or resulting public company, as applicable, into which the Company’s common stock is exchanged or converted in connection with such transaction. The holder may elect to convert all or any portion of the outstanding indebtedness, and the Company may elect to convert all or any portion of the outstanding indebtedness. The conversion price is equal to 50% of VWAP, where VWAP is calculated based on the volume-weighted average price of the applicable issuer’s common stock for the five trading days immediately preceding the applicable conversion date, subject to the calculation mechanics specified in the February 2026 Convertible Note. If the applicable issuer’s common stock is not listed or quoted on a trading market, the February 2026 Convertible Note provides for alternative market price or fair value determinations, as applicable. The VWAP calculation is subject to equitable adjustment for stock dividends, stock splits, combinations, recapitalizations, and similar transactions.

 

The February 2026 Convertible Note is subject to certain conversion limitations, including a 9.99% beneficial ownership limitation and a 19.99% exchange cap, unless the required stockholder approval is obtained or such approval is not required under applicable stock exchange rules.

 

Events of default include, among other matters, failure to pay amounts when due, subject to applicable cure periods, and certain bankruptcy, insolvency, or similar events. Upon an event of default, Pegasus may declare the outstanding indebtedness immediately due and payable, and the interest rate increases to 10% per annum during the continuance of the default.

 

In connection with the Note Purchase Agreement, Pegasus was granted certain piggyback registration rights with respect to shares issuable upon conversion of the February 2026 Convertible Note, including shares of the applicable acquiror, successor, or resulting public company issuable upon conversion in connection with an RTO, subject to the terms and limitations set forth in the Note Purchase Agreement.

 

The February 2026 Convertible Note represents share-settled debt that requires or may require the Company to settle the debt instrument by delivering a variable number of shares determined based on the amount of indebtedness being converted, including accrued and unpaid interest, at a conversion price equal to 50% of the applicable VWAP. The Company elected to apply the fair value option under ASC 825-10 at inception of the note and the liability will be re-measured at fair value at each reporting period with the changes in the fair value of the liability recognized in earnings.

 

As of September 30, 2026, the fair value (which is also the recorded value) of the February 2026 $100,000 Convertible Note was $185,704.

 

For the three months ending September 30, 2026, the Company recorded a loss on the fair value adjustment of convertible debt of $17,163 related to the February 2026 Convertible Note.

 

April 2026 Convertible Note

 

On April 30, 2026, the Legacy Azio entered into a Note Purchase Agreement with AKJ Capital LLC (“AKJ”) pursuant to which Legacy Azio issued and sold to AKJ a convertible promissory note in the principal amount of $50,000 (the “April 2026 Convertible Note”) for a purchase price of $50,000. The proceeds from the issuance of the April 2026 Convertible Note were used for general working capital purposes. This note was assumed by the Company in the Azio acquisition disclosed in Note 3 - Acquisition.

 

The April 2026 Convertible Note bears interest at 5% per annum, calculated on a simple, non-compounding basis, and matures on April 30, 2031, the fifth anniversary of the issuance date, unless earlier converted or prepaid in accordance with its terms. No payments of principal or interest are required prior to maturity, other than as specifically provided in the April 2026 Convertible Note. The Company may prepay all or any portion of the outstanding indebtedness at any time prior to maturity.

 

Upon the occurrence of a Trigger Event, defined in the April 2026 Convertible Note as the occurrence of an IPO of the Company’s common stock or an RTO transaction involving the Company, whichever is first, the April 2026 Convertible Note may be converted, in whole or in part, only beginning on the sixth trading day following such Trigger Event. In the event of an IPO, the April 2026 Convertible Note is convertible into shares of the Company’s common stock. In the event of an RTO or similar transaction, the April 2026 Convertible Note is convertible into shares of common stock of the acquiror, successor, or resulting public company, as applicable, into which the Company’s common stock is exchanged or converted in connection with such transaction. The holder may elect to convert all or any portion of the outstanding indebtedness, and the Company may elect to convert all or any portion of the outstanding indebtedness. The conversion price is equal to 50% of VWAP, where VWAP is calculated based on the volume-weighted average price of the applicable issuer’s common stock for the five trading days immediately preceding the applicable conversion date, subject to the calculation mechanics specified in the April 2026 Convertible Note. If the applicable issuer’s common stock is not listed or quoted on a trading market, the April 2026 Convertible Note provides for alternative market price or fair value determinations, as applicable. The VWAP calculation is subject to equitable adjustment for stock dividends, stock splits, combinations, recapitalizations and similar transactions.

 

The April 2026 Convertible Note is subject to certain conversion limitations, including a 9.99% beneficial ownership limitation and a 19.99% exchange cap, unless the required stockholder approval is obtained or such approval is not required under applicable stock exchange rules.

 

Events of default include, among other matters, failure to pay amounts when due, subject to applicable cure periods, and certain bankruptcy, insolvency, or similar events. Upon an event of default, AKJ may declare the outstanding indebtedness immediately due and payable, and the interest rate increases to 10% per annum during the continuance of the default.

 

In connection with the Note Purchase Agreement, AKJ was granted certain piggyback registration rights with respect to shares issuable upon conversion of the April 2026 Convertible Note, including shares of the applicable acquiror, successor, or resulting public company issuable upon conversion in connection with an RTO, subject to the terms and limitations set forth in the Note Purchase Agreement.

 

The April 2026 Convertible Note represents share-settled debt that requires or may require the Company to settle the debt instrument by delivering a variable number of shares upon conversion determined based on the amount of indebtedness being converted, including accrued and unpaid interest, at a conversion price equal to 50% of the applicable VWAP. The Company elected to apply the fair value option under ASC 825-10 at inception of the note and the liability will be remeasured at fair value at each reporting period with changes in the fair value of the liability recognized in earnings.

 

As of September 30, 2026, the fair value (which is also the recorded value) of the April 2026 $50,000 Convertible Note was approximately $90,617.

 

For the three months ending September 30, 2026, the Company recorded a loss on the fair value adjustment of convertible debt of $9,556 related to the April 2026 Convertible Note.

 

The following table summarizes the Company's long- and short-term debt:

 

  

September 30, 2026

  

December 31, 2025

 

Convertible notes - current

 $1,002,396  $360,462 

Debentures

  7,204,856   - 

Notes payable - other

  83,611   145,297 

Debt - current

 $8,290,863  $505,759 

Line of credit facility

 $1,765,000  $- 

Convertible notes - long-term

  276,321   - 

Total debt

 $10,332,184  $505,759 

 

The following table depicts the future annual minimum payments of the Company's outstanding debt as of September 30, 2026:

 

  

Amount

 

Remainder of 2026

 $5,042,292 

2027

  8,615,586 

2028

  — 

2029

  — 

2030 and beyond

  150,000 

Total Payments

 $13,807,878 

  

 

7.

Stockholders’ Equity

 

The Company has 5,000,000 authorized shares of its preferred stock, par value $0.00001 per share, on September 30, 2026 and December 31, 2025. There were 973,450 outstanding shares of preferred stock on September 30, 2026. There were no outstanding shares of preferred stock on December 31, 2025.

 

The Company has 350,000,000 authorized shares of its common stock, par value $0.00001 per share, of which 17,674,960 and 7,736,129 shares of the Company's common stock were outstanding on September 30, 2026 and December 31, 2025, respectively.

 

As a result of the Azio acquisition, the company issued 973,450 shares of preferred stock and 2,460,351 shares of common stock. See Note 3 - Acquisition for additional disclosures. 

 

The Company also received cash totaling $2,975,000 of issuing 4,792,093 shares of its common stock to fund its business operations. 

 

As notes in Note 6 - Debt, the Company partially repaid its Debentures by issuing 1,153,744 shares of its common stock totaling $1,783,830 and its short-term Convertibles Notes by issuing 623,753 of its common stock totaling $358,658. 

 

During the second quarter of 2026, 291,778 Debenture Warrants were exercised at the exercise price of $0.01 per share. During the third quarter of 2026, 450,000 Debenture Warrants were exercised at the exercise price of $0.01 per share. The intrinsic value of warrants exercised is $1,196,527. Total proceeds received from the exercise of warrants was $7,419.

 

During the third quarter of 2026, the Company issued 167,112 shares of its common stock for future services.

 

 

8.

Stock Warrants

 

The Company’s outstanding warrants as of September 30, 2026 are summarized as follows, and all were exercisable at that date.

 

  

Number of Shares

  

Exercise Price

  

Remaining Contractual Life (years)

 

Outstanding warrants expiring March 6, 2031

  550,000  $0.01   4.43 

Outstanding warrants expiring September 25, 2029

  1,735,758  $0.01   2.99 

Outstanding warrants at September 30, 2026

  2,285,758         

 

10

March 2026 Warrants

 

As disclosed in Note 6 - Debt, the Company issued to the Investor Warrants Debenture to purchase up to 1,291,778 shares of the Company’s common stock at an exercise price of $0.01 per share in conjunction with the issuance of the Debentures during the first quarter of 2026. The Debenture Warrants are immediately exercisable and will expire 60 months from the date of issuance. The Debenture Warrants include customary adjustment provisions for stock splits, combinations and similar events. During the second quarter of 2026, 291,778 Debenture Warrants were exercised at the exercise price of $0.01 per share. During the third quarter of 2026, 450,000 Debenture Warrants were exercised at the exercise price of $0.01 per share. The intrinsic value of warrants exercised is $1,196,527.

 

September 2029 Warrants

 

As disclosed in Note 6 - Debt, the Company issued to the Investor SEPA Warrants to purchase up to 1,735,758 shares of the Company’s common stock at an exercise price of $0.01 per share in conjunction with the issuance of the first tranche of the Azio Pre-Paid Advance received under the SEPA (See Note 6 - Debt) during the third quarter of 2026. The Warrants are immediately exercisable and will expire 36 months from the date of issuance. The SEPA Warrants include customary adjustment provisions for stock splits, combinations and similar events. The intrinsic value of these warrants at September 30, 2026 is $2,187,055.

 

 

9.

Stock Options

 

The outstanding options at  September 30, 2026 consisted of the following:

 

          

Weighted

 
          

Average

 
          

Remaining

 
  

Number of

  

Exercise

  

Contractual Life

 
  

Shares

  

Price

  

(years)

 

Outstanding at December 31, 2025

  977,250        

Options Granted at $2.19 Exercise Price

  1,394,400  $2.19     

Options Expired at $22.00 Exercise Price

  (1,000) $22.00     

Options Expired at $15.00 Exercise Price

  (80,000) $15.00     

Options forfeited at $22.00 Exercise Price

  (1,000) $22.00     

Options forfeited at $90.00 Exercise Price

  (25,000) $90.00     

Options forfeited at $20.00 Exercise Price

  (25,000) $20.00     

Options forfeited at $24.00 Exercise Price

  (9,090) $24.00     

Options forfeited at $21.00 Exercise Price

  (47,650) $21.00     

Options forfeited at $21.10 Exercise Price

  (131,075) $21.10     

Outstanding at September 30, 2026

  2,051,835         

Outstanding Options at $90.00 Exercise Price

  675  $90.00   4.22 

Outstanding Options at $262.00 Exercise Price

  675  $262.00   1.79 

Outstanding Options at $21.00 Exercise Price

  11,200  $21.00   6.77 

Outstanding Options at $21.10 Exercise Price

  5,385  $21.10   7.46 

Outstanding Options at $26.60 Exercise Price

  2,500  $26.60   7.36 

Outstanding Options at $27.50 Exercise Price

  200,000  $27.50   0.34 

Outstanding Option at $17.60 Exercise Price

  10,000  $17.60   7.71 

Outstanding Options at $14.90 Exercise Price

  2,000  $14.90   7.67 

Outstanding Options at $2.50 Exercise Price

  415,000  $2.50   8.44 

Outstanding Options at $2.12 Exercise Price

  10,000  $2.12   8.63 

Outstanding Options at $2.19 Exercise Price

  1,394,400  $2.19   9.62 

Outstanding at September 30, 2026

  2,051,835         

 

As of  September 30, 2026, 1,843,001 of the outstanding stock options were exercisable. Unrecognized compensation for unvested shares was $55,005 as of September 30, 2026.

 

As of September 30, 2026, the outstanding stock options had intrinsic value of $0.

 

On  May 22, 2026, the Compensation Committee of the Company's Board of Directors granted the Company's non-employee directors and certain executives and consultants of the Company options to purchase 1,394,400 shares of common stock at an exercise price of $2.19 per share, all of which vested immediately upon grant and expire on the tenth anniversary of the grant date. The fair values of these options were calculated using the Black-Scholes valuation methodology. The inputs used are: (1) risk-free rate of 4.27%, (2) expected term of 5 years, (3) volatility of 111.4% and (4) exercise price of $2.19.

 

Performance Options

 

On February 28, 2024, the Company issued options to an external party to purchase 200,000 shares of the Company's common stock at an exercise price of $27.50 per share, contingent upon achieving certain sales targets. On September 30, 2026, the sales targets were not met and therefore, no compensation expense was recorded for the nine months ended September 30, 2026. The Company does not believe that the criteria will be met. These options expire on February 5, 2027.

 

Common Stock Issued for Outside Consulting Services

 

On July 31, 2026, the Company entered into a marketing agreement whereby the Company issued 167,112 shares of its common stock in exchange for marketing services to be performed from August 7, 2026 through February 8, 2027 at fair value of $136,083 and compensation expense will be recognized pro-ratably over the requisite service period.

 

11

 
 

10.

Related Party Transactions

 

The Company has entered into month-to-month lease agreements with SRI Professional Services, Incorporated (“SRI”), pursuant to which the Company leases equipment used in connection with the operation of its business (the “SRI Equipment Leases”). Phillip W. Oldridge, the Company’s former Chief Executive Officer and Chairman of the Board, serves as an executive officer and a member of the board of directors of SRI. Two of the SRI Equipment Leases provide for the leasing of two vehicles that commenced on  January 1, 2020 and the combined rent under such leases is $3,880 per month, and a third SRI Equipment Lease provides for a trailer lease that commenced on  December 1, 2019, under which the rent is $3,891 per month. The total monthly payment obligation of the Company under the SRI Equipment Leases is $7,771. The Company recorded rent expense of $23,312 and $23,312 for the three months ended September 30, 2026 and 2025, respectively. The Company recorded rent expense of $69,936 and $69,936 for the nine months ended September 30, 2026 and 2025, respectively. 

 

The Company has entered into a month-to-month commercial lease agreement (the “ABCI Office Lease”) with Alpha Bravo Charlie, Inc. (“ABCI”) that commenced on  April 1, 2020, for the lease of office space in Porterville, California. The monthly rent for this facility is approximately $5,000. Phillip W. Oldridge, the Company’s former Chief Executive Officer and Chairman of the Company's Board of Directors, is a director of ABCI. The Company recorded rent expense of $15,000 and $15,000 for the three months ended September 30, 2026 and 2025, respectively. The Company recorded rent expense of $45,000 and $45,000 for the nine months ended September 30, 2026 and 2025, respectively. The outstanding balance at September 30, 2026 and December 31, 2025 are $46,082 and $90,380, respectively.

 

The Company expensed $131,000 and $131,000 for the three months ended September 30, 2026 and 2025, respectively, to Shell Castle LLC, an entity owned by Jason Maddox, the Company's Chief Financial Officer for executive management and financial services provided as an independent service provider. The Company expensed $393,000 and $221,000 for the nine months ended September 30, 2026 and 2025, respectively, to Shell Castle LLC. The outstanding balance at September 30, 2026 and December 31, 2025 is $87,333 and $262,000, respectively.

 

The Company expensed $131,000 and $15,000 for the three months ended September 30, 2026 and 2025, respectively, to Met Consulting LLC, an entity owned by Elgin Tracy, the Company's Chief Operating Officer, for executive management provided as an independent service provider. The Company also expensed $393,000 and $105,000 for the nine months ended September 30, 2026 and 2025, respectively, to Met Consulting LLC. The outstanding balance at September 30, 2026 and December 31, 2025 is $57,333 and ($30,000), respectively.

 

The Company expensed $82,609 for the three months ended September 30, 2026 to Listed Ventures, an entity owned by Simon Yu, President,  for executive management provided as an independent service provider. The Company expensed $50,000 for the three months ended September 30, 2026 to Milthea Company Inc., an entity owned by Gary Chen for services rendered as an executive officer of the Company as an independent service provider. The outstanding balance at September 30, 2026 and December 31, 2025 is $0 and $0, respectively.

 

The Company expensed $82,609 for the three months ended September 30, 2026 to Alora Group, an entity owned by David Shiue for services rendered as a greater than 5% shareholder of the Company.

 

All revenue earned for the three and nine months ended September 30, 2026 and 2025 by the Company's medical supplies segment was from Maddox Medical Corp. ("Maddox Medical"), a company owned by Jason Maddox, Chief Financial Officer of the Company, through a contract that Maddox Medical holds with a third party (that supplies medical gowns, among other things, to the federal government) that is fulfilled by Maddox Industries, a wholly-owned subsidiary of the Company. The outstanding balance at September 30, 2026 and December 31, 2025 is $263,356 and $3,533, respectively.

 

On April 1, 2025, the Company entered into a three-year sub-lease arrangement with Maddox Medical (with renewal options), an entity of which Jason Maddox, the Chief Financial Officer of the Company, is the sole stockholder, to lease a facility in Houston, Texas for its corporate and administrative operations. See Note 12 - Leases for additional disclosures.

 

The Company expensed $32,475 and $32,475 for the three months ended September 30, 2026 and 2025, respectively, to Michael di Pietro, Independent Director and Chairman of the Audit Committee for services rendered as an independent board member. The Company expensed $97,425 and $97,425 for the nine months ended September 30, 2026 and 2025, respectively, to Michael di Pietro. The outstanding balance at September 30, 2026 and December 31, 2025 is $32,475 and $32,475, respectively.

 

On April 1, 2026, the Company entered into a nine-month lease arrangement with CAVOK Air Texas LLC ("CAVOK") (with automatic one-year renewals), an entity related to certain executives of the Company for vehicle storage. The monthly payment for this lease is $12,500.

 

As disclosed in Note 6 - Debt, the Company entered into the Credit Agreement with the Lender, providing for an unsecured revolving credit facility of up to $2,300,000. Chi Wei David Shiue, the former Chief Business Development Officer of the Company and the sole member of Alora LLC, a beneficial owner of more than five percent (5%) of the outstanding shares of the Company’s common stock, is the Chief Executive Officer and President and a majority shareholder of the Lender. See also Note 10 - Related Party Transactions. The balance of the Credit Facility at September 30, 2026 is $1,765,000.

 

12

 
 

11.

Commitments and Contingencies

 

Commitments

 

See Note 12 - Leases for further information.

 

Contingencies

 

Except as set forth below, we know of no material, existing or pending, legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder of more than 5% of our common stock, or any associate of any of the foregoing persons, is an adverse party or has a material interest adverse to our interest.

 

GreenPower Litigation

 

The Company is named as a defendant in litigation commenced in the Supreme Court of British Columbia, Canada, originally filed on  December 17, 2019 by GreenPower Motor Company Inc. (“GreenPower”), along with certain related entities and individuals, including an executive officer of the Company. The claims generally allege, among other things, breach of fiduciary duty, misuse of confidential information, unfair competition, and related matters. The Company and the other named defendants have denied these allegations. In addition, certain of the defendants, including the Company, are named in a related counterclaim proceeding.

 

The litigation was previously scheduled for trial in 2024; however, the trial was adjourned by consent of the parties. As of September 30, 2026, no new trial date has been set, limited discovery has been conducted, and there has been no material activity in the proceedings during fiscal year 2025. The matter remains in an early procedural stage.

 

Lawsuit against Efraim Diveroli and Kingbird Ventures LLC

 

On  February 5, 2026, the Company sued Efraim Diveroli and Kingbird Ventures LLC in the Houston Division of the Texas Business Court, alleging that the defendants, acting individually and in concert with one another, caused  agents and representatives of theirs, including Joel E. Tasca of Greenberg Traurig, to spread lies about the Company, its principals, and its business partners in an effort to scuttle the expected merger with Azio AI Corporation. The Company asserted claims for tortious interference with contract, tortious interference with prospective economic advantage, and defamation and business disparagement as well as seeking emergency and temporary injunctive relief. On  February 9, 2026, Kingbird Ventures removed the case to the United States District Court for the Southern District of Texas. An initial pretrial and scheduling conference is set on  May 28, 2026. No scheduling order has been entered, nor has a trial date been set.

 

Lawsuit against Efraim Diveroli, Kingbird Ventures LLC, VD Acquisitions, LLC, Bront Bird, and Karla Mae Capital, LLC 

 

On  December 8, 2025, the Company and Maddox Defense, Inc. (“Maddox Defense”), an entity wholly owned by Jason Maddox, the Company’s Chief Financial Officer, sued Efraim Diveroli, Kingbird Ventures LLC, VD Acquisitions, LLC, Bront Bird, and Karla Mae Capital, LLC in the Southern District of California, alleging that defendants, acting individually and in concert with one another, engaged in coercive and extortionate activities, including through abuse of the legal process, in an attempt to force the Company into unwanted transactions, including with Fenix Oro, a gold-mining enterprise. The Company asserted claims for civil extortion; RICO, 18 U.S.C. § 1962(c); fraudulent inducement; tortious interference with contract; tortious interference with prospective economic relations; abuse of process; declaratory relief; injunctive relief; civil conspiracy; and unfair competition, Bus. & Prof. Code § 17200. On  January 7, 2026, the claims against Bront Bird and Karla Mae Capital were voluntarily dismissed with prejudice. No responsive pleadings have been filed. No scheduling order has been entered, nor has a trial date been set. 

 

Lawsuit from VD Acquisitions

 

On  January 14, 2026, VD Acquisitions LLC ("VD Acquisitions")  filed suit against Jason Maddox, Elgin Tracy, Maddox Defense; Maddox Industries, a wholly-owned subsidiary of the Company, the Company, Phillip Oldridge, Karla Mae Capital, LLC and Airboss Defense Group, LLC, alleging that Maddox Defense had failed to perform under a fuel agreement. Plaintiff asserted claims for breach of contract, fraud in the inducement; fraudulent transfer; civil conspiracy; intentional interference with contract; and declaration of alter ego. The plaintiff seeks monetary damages and injunctive relief restraining the assets of Jason Maddox, Maddox Defense, Maddox Industries, and the Company. On  February 10, 2026, the Court held a hearing on the plaintiff’s motion for a temporary restraining order and denied the requested relief. The Company disputed these allegations and vigorously defended itself. The Company was successful and VD Acquisitions withdrew its case in the Delaware Courts in April 2026.

 

Litigation with Former Independent Auditor

 

In  December 2025, the Company initiated legal proceedings against its former independent registered public accounting firm, MaloneBailey LLP (“MaloneBailey”), in the United States District Court for the Central District of California (Case No. 5:25-cv-03457). The complaint alleges, among other things, breach of contract and related claims arising from MaloneBailey’s engagement to audit the Company’s financial statements for the fiscal year ended  December 31, 2022. Specifically, the Company asserts that MaloneBailey failed to complete required audit procedures and did not issue an audit report in connection with the Company’s Annual Report on Form 10-K for the 2022 fiscal year, despite having been engaged to do so.

 

MaloneBailey previously served as the Company’s independent auditor. During 2023, the Company disclosed that MaloneBailey would not provide an audit opinion on the Company’s financial statements for the fiscal year ended  December 31, 2022. As a result, the Company engaged a successor independent registered public accounting firm to complete the audit and support its financial reporting obligations. 

 

The Company’s claims are based on alleged contractual breaches and professional failures related to MaloneBailey’s audit engagement. The Company is seeking damages and other relief deemed appropriate by the court. As of September 30, 2026, the litigation is in its early stages. The complaint was recently filed, and no substantive rulings have been issued by the court. The Company cannot predict the timing or outcome of this matter.

 

13

   
 

12.

Leases

 

Operating leases

 

The Company has active operating lease arrangements for office space and warehouse facilities. The Company is typically required to make fixed minimum rent payments relating to its right to use the underlying leased assets. Although these leases have terms that are either month-to-month or terms that are one year or less (with renewal options), the Company concluded that the term renewal options are reasonably certain to be exercised, and the Company classified such leases as operating leases in accordance with the provisions of ASC 842.

 

On April 1, 2026, the Company entered into a nine-month lease arrangement with CAVOK (with automatic one-year renewals). This lease is treated as an operating lease in accordance with the provisions of ASC 842. Therefore, the Company recognized operating lease liabilities with corresponding ROU assets based on the present value of the minimum rental payments of such leases. The Company shall fund approximately $250,000 in parking lot and infrastructure improvements associated with grading, stabilization, drainage, striping, lighting, electrical preparation, charging-readiness, staging areas, asphalt and concrete work, and related site improvements supporting approximately 100 vehicle parking and charging spaces. The monthly payment is $12,500.

 

On March 1, 2026, the Company entered into a one-year lease arrangement with TexOil Ventures LLC ("TexOil") (with one-year renewal options) for pilot infrastructure and computing operations. This lease is treated as an operating lease in accordance with the provisions of ASC 842. Therefore, the Company recognized operating lease liabilities with corresponding ROU assets based on the present value of the minimum rental payments of such leases. The Company paid a nonrefundable deposit of $390,000 and will make monthly payments of $38,500 to TexOil. The Company granted TexOil a first-priority security interest in all computing and mining equipment located at the leased site. Upon default by the Company and expiration of the applicable cure period, TexOil may foreclose and take title to such equipment under the Texas Uniform Commercial Code.

 

On April 1, 2025, the Company entered into a three-year sub-lease arrangement with Maddox Medical (with renewal options), an entity of which Jason Maddox, the Chief Financial Officer of the Company, is the sole stockholder, to lease a facility in Houston, Texas for its corporate and administrative operations. This lease is treated as an operating lease in accordance with the provisions of ASC 842. Therefore, the Company recognized operating lease liabilities with corresponding ROU assets based on the present value of the minimum rental payments of such leases. The current monthly payment is $20,482 with escalating rent payments of 4% per year.

 

The Company's lease agreements do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate incremental borrowing rate. The Company benchmarked itself against other companies of similar credit ratings and comparable credit quality and derived an incremental borrowing rate to discount each of its lease liabilities based on the remaining lease terms.

 

14

 

Quantitative information regarding the Company’s leases is as follows:

 

  

Three Months Ended

  

Nine Months Ended

 
  

September 30,

  

September 30,

 
  

2026

  

2025

  

2026

  

2025

 

Lease expenses

                

Operating lease expenses

 $285,552  $99,863  $604,988  $238,038 

Short-term lease expenses

  142,268   30,076   282,318   127,649 

Total lease cost

 $427,820  $129,939  $887,306  $365,687 
                 

Other information

                

Cash paid for the amounts included in the measurement of lease liabilities for operating leases:

                

Operating cash flows

 $212,091  $97,402  $448,136  $233,116 

Weighted-average remaining lease term (in years):

                

Operating leases

  2.37   2.50   2.37   2.50 

Weighted-average discount rate:

                

Operating leases

  14%  14%  14%  14%

 

The discount rate was determined using the Company’s external debt and was adjusted for collateralization, term and lease amount.

 

Future minimum payments under operating leases are as follows:

 

Remainder of 2026

 $258,393 

2027

  865,192 

2028

  547,217 

2029

  115,500 

Total undiscounted cash flows

  1,786,302 

less amount representing interest

  (243,000)

Present value of lease liabilities

  1,543,302 

less current portion

  (742,008)

Non-current lease liabilities

  801,294 

 

 

13.

Fair Value Measurements

 

 

  

As of September 30, 2026

 
  

Fair Value

  

Level 1

  

Level 2

  

Level 3

 

Liabilities:

                

February 2026 Convertible Note

 $185,704  $-  $-  $185,704 

April 2026 Convertible Note

  90,617   -   -   90,617 

March 2026 Debenture

  3,228,816   -   -   3,228,816 

May 2026 Debenture

  3,976,040   -   -   3,976,040 

Line of credit facility from related party

  1,765,000         1,765,000 

Convertible Note (SEPA)

  1,002,396   -   -   1,002,396 

Other Debt

  83,611         83,611 

Balance as of September 30, 2026

 $10,332,184  $-  $-  $10,332,184 

 

  

As of December 31, 2025

 
  

Fair Value

  

Level 1

  

Level 2

  

Level 3

 

Liabilities:

                

Convertible Notes

 $360,462  $-  $-  $360,462 

Other Debt

  145,297         145,297 

Balance as of December 31, 2025

 $505,759  $-  $-  $505,759 

 

 

14.

Segment Reporting

 

The Chief Operating Decision Maker is the Chief Executive Officer, who reviews the segment operating results in order to allocate resources and assess performance.

 

The Company has identified four segments:

 

(1) Electric vehicles,

 

(2) Medical supplies, 

 

(3) AI Infrastructure, and

 

(4) Drones.

 

The electric vehicle segment consists of sales of commercial electric vehicles to customers. A significant portion of such sales are through state subsidized or funded programs. The medical supplies segment consists solely of sales to Maddox Medical, a related party based on an agreement to supply refurbished medical gowns on a cost-plus pricing arrangement. The AI Data Infrastructure segment is operated through our acquired entity as described in Note 3 - Acquisition. Through the Company's drone operations, it is also diversifying its portfolio of assets by engaging in the future production and supply of drones that will be used in the agricultural environment. Currently, activity within the drones segment is limited to start up expenses and research and development activities.

 

The tables below summarize the operating results of the Company's segments for the three and nine months ended September 30, 2026 and 2025: 

 

  

Three months ended September 30, 2026

 
  

Electric vehicles

  

Medical Supplies

  

AI Data Infrastructure

  

Drones

  

Corporate

  

Total

 

Sales, net

 $-  $1,872,271  $-  $-  $-  $1,872,271 

Operating Income (Loss)

 $(1,019,482) $68,181  $(1,085,893) $-  $(4,130,972) $(6,168,166)

Gain on conversion and changes in fair value of convertible notes

  -   -   -   -   -   330,175 

Other expenses

  -   -   -   -   -   (11,743)

Income tax (benefit)/expense

  -   -   -   -   -   (108,151)

Net loss

                     $(5,741,583)

 

  

Three months ended September 30, 2025

 
  

Electric vehicles

  

Medical Supplies

  

AI Data Infrastructure

  

Drones

  

Corporate

  

Total

 

Sales, net

 $-  $1,812,461  $-  $-  $-  $1,812,461 

Operating loss

 $(3,057,470) $(2,994,693) $-  $(11,031) $-  $(6,063,194)

Interest income (expense), net

  -   -   -   -   -   21,979 

Loss on conversion and changes in fair value of convertible notes

  -   -   -   -   -   (312,812)

Other expenses

  -   -   -   -   -   (3,530)

Income tax (benefit)/expense

  -   -   -   -   -   - 

Net loss

                     $(6,357,557)

 

  

Nine months ended September 30, 2026

 
  

Electric vehicles

  

Medical Supplies

  

AI Data Infrastructure

  

Drones

  

Corporate

  

Total

 

Sales, net

 $-  $6,783,779  $-  $-  $-  $6,783,779 

Operating Income (Loss)

 $(1,446,359) $(110,090) $(1,283,226) $(10,000) $(12,826,640) $(15,676,315)

Interest income (expense), net

  -   -   -   -   -   50 

Loss on conversion and changes in fair value of convertible notes

  -   -   -   -   -   (670,452)

Other expenses

  -   -   -   -   -   (127,356)

Income tax (benefit)/expense

  -   -   -   -   -   (108,151)

Net loss

                     $(16,365,922)

 

  

Nine months ended September 30, 2025

 
  

Electric vehicles

  

Medical Supplies

  

AI Data Infrastructure

  

Drones

  

Corporate

  

Total

 

Sales, net

 $348,063  $3,101,993  $-  $-  $-  $3,450,056 

Operating loss

 $(19,581,724) $(4,335,105) $-  $(677,665) $-  $(24,594,494)

Interest income (expense), net

  -   -   -   -   -   33,035 

Loss on conversion and changes in fair value of convertible notes

  -   -   -   -   -   (963,513)

Other expenses

  -   -   -   -   -   (15,703)

Income tax (benefit)/expense

  -   -   -   -   -   - 

Net loss

                     $(25,540,675)

 

 

15.

Subsequent Events

 

The Company evaluates subsequent events that have occurred after the balance sheet date but before the unaudited condensed consolidated financial statements are issued. There are two types of subsequent events: (1) recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing financial statements, and (2) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date. 

 

Revolving Credit Facility Agreement

 

On October 21, 2026, the Company entered into the Credit Agreement, providing for Credit Facility of up to $2,300,000, inclusive of the Prior Advances. Pursuant to the Credit Agreement, the Company  may, from time to time, request Loans from the Lender, up to the Loan Commitment. The Lender may, in its sole discretion, fund any Loan that would cause the aggregate principal balance of the Loans to exceed the Loan Commitment upon its prior written consent. Amounts borrowed under the Credit Agreement shall be evidenced by Revolving Promissory Note payable to the order of the Lender. Prior to entering into the Credit Agreement, the Lender provided advances to the Company in an aggregate amount totaling $2,225,000. Pursuant to the Credit Agreement, the Company and the Lender agreed that the Prior Advances shall be deemed Loans and subject to the terms and conditions thereunder as of the Effective Date. Proceeds from the Credit Agreement may be used for working capital for the Company and such other uses as determined by the Company's Board of Directors.

 

Annual Meeting of Shareholders

 

On November 13, 2026, the Company held the Annual Meeting of Shareholders and the following proposals were passed:

 

 

●

The Company’s stockholders elected Larry G. Paige II to serve as a Class III director on the Board to hold office for a three-year term expiring at the Company’s 2029 Annual Meeting of Stockholders or until his successor has been duly elected and qualified or until his earlier resignation, removal or death.

 

 

●

The Company’s stockholders approved the proposal to ratify the appointment of TAAD LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

 

 

●
 

The Company’s stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers in fiscal year 2025.

 

 

●
 

The Company’s stockholders approved the Azio AI Holdings, Inc. 2026 Equity Incentive Plan.

 

 

●
 

The Company’s stockholders approved the adjournment of the Annual Meeting with respect to one or more of the proposals to a later date or dates, if necessary or appropriate, as determined by the Chairman of the Board, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any such proposals at the Annual Meeting or if the Company’s initial listing application required by Nasdaq Listing Rule 5110(a) has not yet been approved.

 

15

 
  
 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

In this Management’s Discussion and Analysis, “we,” “us,” “our” and the “Company” refer to Azio AI Holdings, Inc. and its consolidated subsidiaries, unless the context indicates otherwise. The following discussion of our financial condition and the results of operations should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this Quarterly Report on the Form 10-Q (this "Quarterly Report") and the audited consolidated financial statements and notes thereto included Annual Report on Form 10-K for the year ended December 31, 2025 (the"2025 Annual Report"). This discussion contains forward-looking statements that are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties, and other factors include, among others, those identified under the “Special Note Regarding Forward-Looking Statements” above in this Quarterly Report.

 

Overview

 

Azio AI Holdings, formerly known as Envirotech Vehicles, Inc., historically operated as a United States distributor of zero-emission commercial vehicles and heavy capacity drones engineered for logistics, infrastructure, and precision agriculture applications worldwide, with systems designed to enable a cleaner, safer, and more efficient future for critical industrial operations. On July 2, 2026, we completed our acquisition of Azio AI Corporation (“Legacy Azio”) pursuant to an Amended and Restated Agreement and Plan of Merger, dated July 2, 2026 (the “Merger Agreement” and the transactions contemplated by the Merger Agreement, the “Azio Acquisition”), by and among us, Legacy Azio, EV-AZ Merger Sub, Inc., a wholly owned subsidiary of the Company (“First Merger Sub”), and Azio AI, LLC, a wholly owned subsidiary of the Company (“Second Merger Sub”). The Merger Agreement amended and restated in its entirety a prior merger agreement between the parties that was entered into on May 19, 2026, and announced on May 20, 2026. In connection with the Azio Acquisition, we changed our corporate name to “Azio AI Holdings, Inc.” and our common stock, per value $0.00001 per share (the "Common Stock"), began trading on the Nasdaq Capital Market of The Nasdaq Stock Market LLC ("Nasdaq") under the symbol “AZIO” effective July 13, 2026. As a result of the Azio Acquisition, we have expanded our business to become a technology infrastructure company focused on developing, owning and operating artificial intelligence (“AI”) data centers, enterprise graphics processing unit (“GPU”) compute infrastructure, high-performance computing systems, and digital power solutions, in addition to our legacy electric vehicle, medical supplies and drone businesses. We believe the combination of our legacy industrial vehicle and logistics expertise with Legacy Azio’s AI infrastructure platform positions us to capitalize on the rapidly expanding global demand for AI infrastructure, compute capacity, digital power, and next-generation AI technologies.

 

For the three months ended September 30, 2026 and 2025, we generated sales revenue of $1,872,271 and $1,812,461 respectively, and our net loss for the three months ended September 30, 2026 and 2025 was $5,741,583 and $6,357,557, respectively. Included in our net loss for the three months ended September 30, 2026 is a gain on conversion and changes in fair value of convertible notes of $330,175 and an out of period adjustment for stock-based compensation of $860,428. See Note 2 - Summary of Significant Accounting Policies for further disclosure. Included in our net loss for the three months ended September 30, 2025 is a loss on conversion and changes in fair value of convertible notes of $312,812. 

 

For the nine months ended September 30, 2026 and 2025, we generated sales revenue of $6,783,779 and $3,450,056 respectively, and our net loss for the nine months ended September 30, 2026 and 2025 was $16,365,922 and $25,540,675, respectively. Included in our net loss for the nine months ended September 30, 2026 is a loss on conversion and changes in fair value of convertible notes of $670,452. Included in our net loss for the nine months ended September 30, 2025 is a loss on conversion and changes in fair value of convertible notes of $963,513, a non-cash impairment charge of $10,103,048 for goodwill and a non-cash impairment charge of $3,300,801, respectively. 

 

Merger with Azio AI Corporation

 

As disclosed in Note 1 - Organization and Operations to the unaudited consolidated financial statements included in this Quarterly Report, on July 2, 2026, the Company acquired Legacy Azio pursuant to the Merger Agreement and the transactions contemplated by the Merger Agreement. Pursuant to the Merger Agreement, First Merger Sub merged with and into Legacy Azio, pursuant to which Legacy Azio was the surviving corporation and became a wholly owned subsidiary of the Company (the “First Merger”) and immediately following the effective time of the First Merger (the “First Effective Time”), Legacy Azio merged with and into Second Merger and, together with the First Merger, the “Mergers”), pursuant to which Second Merger Sub was the surviving entity and became a wholly owned subsidiary of the Company.

 

At the closing of the Azio Acquisition, the Company issued to former Legacy Azio stockholders (i) 2,460,351 shares of the Company's common stock, representing no more than 19.9% of the Company's outstanding common stock immediately prior to the closing, net of 194,807 shares issuable upon conversion of $150,000 aggregate principal amount of Legacy Azio convertible notes assumed by the Company, and (ii) 973,450 shares of the Company's Series A Non-Voting Convertible Preferred Stock (the “Series A Preferred Stock”). No fractional shares were issued. Any fractional interests were aggregated and any remaining fractional shares were rounded up to the nearest whole share. Each share of Series A Preferred Stock is convertible into 100 shares of common stock upon approval by the Company's stockholders of a proposal to permit such conversion under Nasdaq Listing Rule 5635.

 

The Azio Acquisition allows the Company to enhance its AI infrastructure business segment to offer the following services:

 

 

●

AI datacenter deployment

 

●

Enterprise GPU compute

 

●

Digital power infrastructure

 

●

Data center development and digital asset infrastructure

 
One Big, Beautiful Bill Act (the "Act")
 
The demand for our vehicles may be affected adversely by the Act due to significant reductions in electric vehicle credits made available to consumers. This may affect our future profitability.
 
Import Tariffs
 
Tariffs imposed by the Presidential administration may significantly affect demand for our vehicles or reduce our gross profits if we are unable to pass such tariffs to our customers. We are currently assessing the impact and will take appropriate action to minimize the impact of such tariffs on our electric vehicle strategy.
 
Nasdaq Deficiency Notice

 

On April 29, 2026, we received a notice (the “Notice”) from the Listing Qualifications Department of Nasdaq (the “Department”) notifying us that, because our stockholders’ equity was below $2,500,000 as reported on the 2025 Annual Report, we no longer meet the minimum shareholders’ equity requirement of $2,500,000 for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(2)(C), the Company had 45 calendar days, or until June 13, 2026, to submit to Nasdaq a plan to regain compliance. If the Company’s plan was accepted, Nasdaq could grant an extension of up to 180 calendar days from the date of the Notice, or until October 26, 2026, to evidence compliance with the Minimum Stockholders’ Equity Requirement.

 

The Company submitted the required compliance plan to Nasdaq before June 13, 2026, and on June 18, 2026, the Company received notice from the Department that the Nasdaq staff had determined to grant the Company an extension to regain compliance with the Minimum Stockholders’ Equity Requirement until October 26, 2026 subject to the satisfaction of certain conditions set forth in the notice.

 

Following the closing of the Azio Acquisition, we received notice from the Department on November 3, 2026, that, based on our Current Report on Form 8-K filed with the SEC on October 26, 2026, the Nasdaq staff has determined that we comply with the Minimum Stockholders’ Equity Requirement.

 

Going Concern and Management’s Plan

 

Our unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We sustained significant losses and negative cash flows from operations and are dependent on the overall improvement of our operating activities as well as debt and equity financing to fund operations. We incurred a net loss of $5,741,583 and $16,365,922 for the three and nine months ended September 30, 2026, respectively. We incurred a net loss of $6,357,557 and $25,540,675 for the three and nine months ended September 30, 2025, respectively. Cash used in operating activities was $11,665,967 and $6,295,792 for the nine months ended September 30, 2026 and 2025, respectively. Accumulated deficit was $128,954,382 and $112,588,460 as of September 30, 2026 and December 31, 2025, respectively. 

 

As a result of these conditions, substantial doubt exists about our ability to continue as a going concern within one year after the filing of this Quarterly Report. The unaudited consolidated financial statements included elsewhere herein do not include any adjustments that might be necessary if we were unable to continue as a going concern.

 

As more fully described below under “Debenture Financing,” we closed the initial tranche of Debentures on March 6, 2026, resulting in net proceeds of $3,815,000, and closed the second tranche on May 6, 2026, resulting in net proceeds of $6,720,000. We also obtained another $2,880,000 in advances under the SEPA as discussed in Note 6 - Debt.

 

We also expanded our operations into the artificial intelligence and data center infrastructure sector through the Azio Acquisition. A significant portion of the capital raised to date and expenditures incurred in connection with these operations has been deployed toward infrastructure, equipment, site development and other expenditures intended to establish the foundation for commissioning and operating revenue-producing AI data center capacity.

 

Management's plans to address the conditions giving rise to substantial doubt include: (i) commissioning and placing into service income-producing data center capacity; (ii) generating revenue from hosting, infrastructure and equipment sales arrangements; (iii) obtaining project-level financing to fund additional data center development and expansion; (iv) raising additional capital through debt or equity financings, as appropriate; and (v) managing operating expenditures as the Company's AI infrastructure operations scale.

 

Future financing proposals, indications of interest and other preliminary commitments may be subject to due diligence, definitive documentation, satisfaction of closing conditions and other contingencies and, unless and until definitive agreements are executed and applicable conditions are satisfied, there can be no assurance that such financing will be consummated on acceptable terms or at all. There can also be no assurance as to the timing of commissioning additional data center capacity, the amount or timing of revenues generated from such capacity, the realization of anticipated benefits from the Azio Acquisition, or the Company's ability to achieve positive operating cash flows.

 

Accordingly, while management believes that its strategic assets, commercial pipeline, financing alternatives and planned commencement and expansion of revenue-generating AI data center operations provide a basis for its plans to improve liquidity and operating results, these plans are not considered probable of being fully implemented within the applicable assessment period to the extent necessary to alleviate the substantial doubt regarding the Company's ability to continue as a going concern.

 

16

 

Components of Results of Operations

 

Sales

 

Sales are recognized in accordance with ASC 606, as discussed in Note 2 to our unaudited consolidated financial statements included in this Quarterly Report. Under the vehicles segment, sales are recognized from the sales of new, purpose-built zero-emission electric vehicles and from providing vehicle maintenance and safety inspection services. Under the medical supplies segment, revenue is initially recognized to the extent of incurred labor costs while the profit margin is recognized when the medical supplies are delivered to the third-party customer.

 

Cost of Sales

 

Cost of sales for our electric vehicles segment includes those costs related to the development, manufacture, and distribution of our electric vehicles. Specifically, we include in cost of sales for our electric vehicles segment each of the following: material costs (including commodity costs); freight costs; labor and other costs related to the development and manufacture of our electric vehicles; and other associated costs. Cost of sales also includes costs related to the valuation of inventory due to impairment, obsolescence, or shrinkage. Cost of sales included in our medical supplies activities include direct labor. The main materials of our medical supplies segment are supplied by the customer and are not included as cost of sales.

 

General and Administrative Expenses

 

Selling, general and administrative expenses include all corporate and administrative functions that support our Company, including personnel-related expense and stock-based compensation costs; costs related to investor relations activities; including product recall and customer satisfaction program costs; consulting costs; marketing-related expenses; and other expenses that cannot be included in cost of sales.

 

Consulting and Research and Development Costs

 

These expenses are related to our consulting and research and development activity.

 

Other (Expense)Income, Net

 

Other (expense)/income include non-operating income and expenses, including interest income and expense, realized gain/(loss) on conversion of convertible notes and unrealized gain (loss) of financial instruments at fair value.

 

17

  

Provision for Income Taxes

 

We account for income taxes in accordance with ASC 740 which requires the recognition of deferred income tax assets and liabilities for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that we will not realize tax assets through future operations. We recorded an income tax benefit of $108,151 for the three and nine months ended September 30, 2026.

 

Results of Operations

 

Net loss for the three months ended September 30, 2026 includes $860,428 of stock-based compensation expense attributable to the three months ended June 30, 2026, recorded as an out-of-period adjustment. See Note 2 - Summary of Significant Accounting Policies.

 

The following discussion compares our results of operations for the three and nine months ended September 30, 2026 to the corresponding periods ended September 30, 2025:

 

Sales

 

Sales for the three months ended September 30, 2026 and 2025 were $1,872,271 and $1,812,461, respectively. Sales for the three months ended September 30, 2026 of our electric vehicle segment was $0. All sales for the three months ended September 30, 2026 consisted of margin and services associated with the delivery of medical supplies to a related party. Sales for the three months ended September 30, 2025 of our electric vehicle segment was $0. Sales of our medical supplies segment consisted of margin and services associated with the delivery of medical supplies totaling $1,812,461 to a related party. 

 

Sales for the nine months ended September 30, 2026 and 2025 were $6,783,779 and $3,450,056, respectively. All sales for the nine months ended September 30, 2026 consisted of margin and services associated with the delivery of medical supplies to a related party. Sales for the nine months ended September 30, 2025 of our electric vehicle segment were $348,063 and consisted primarily of two logistics cargo vans and two cab and chassis trucks. Sales of our medical supplies segment consisted of margin and services associated with the delivery of medical supplies totaling $3,101,993 to a related party. 

 

Cost of Sales

 

Cost of sales for the three months ended September 30, 2026 and 2025 were $1,909,668 and $1,731,667, respectively. Cost of sales of our electric vehicles segment was $19,463 and $23,310 for the three months ended September 30, 2026 and 2025, respectively. Cost of sales of our medical supplies segment was $1,787,258 and $1,708,357 for the three months ended September 30, 2026 and 2025, respectively. Cost of sales for our AI data infrastructure segment was $102,947 for the three months ended September 30,2026. Cost of sales for our electric vehicles segment in 2025 was related to the sales of the trucks and a van and additional inventory write-downs while cost of sales for our medical supplies segment was based on a cost-plus pricing structure to a related party. 

 

Cost of sales for the nine months ended September 30, 2026 and 2025 were $6,938,459 and $4,707,588, respectively. Cost of sales of our electric vehicles segment was $227,674 for the nine months ended September 30, 2026. Cost of sales of our medical supplies segment was $6,607,838 for the nine months ended September 30, 2026 and was based on a cost-plus pricing structure to a related party. Cost of sales for our AI data Infrastructure segment was $102,947 for the nine months ended September 30, 2026. Cost of sales of our electric vehicles segment was $1,811,386 for the nine months ended September 30, 2025. Cost of sales of our medical supplies segment was $2,896,202 for the nine months ended September 30, 2025. Cost of sales for our electric vehicles segment was related to the sales of electric vehicles and additional inventory write-downs of $1,172,302 while cost of sales for our medical supplies segment was based on a cost-plus pricing structure to a related party.

 

General and Administrative ("G&A") Expenses

 

G&A expenses were $6,118,769 and $2,781,148 for the three months ended September 30, 2026 and 2025, respectively. The increase in G&A costs were primarily due to higher payroll and benefit costs due to additional employees and certain payroll increases, higher rent as we needed additional space for our operations, higher legal fees incurred due to increased compliance activities, higher intangibles amortization as a result of the Azio acquisition discussed elsewhere, partially offset by lower contract labor, lower licenses, lower utilities as we reduced activity in our Arkansas location, lower insurance costs as we undertook certain cost cutting measures with respect to our policies, and overall lower costs due to certain cost cutting measures that were implemented. We also recorded an out of period adjustment of $860,428 for stock-based compensation. See Note 2 - Summary of Significant Accounting Policies.

 

G&A expenses were $15,487,635 and $9,136,044 for the nine months ended September 30, 2026 and 2025, respectively. The increase in G&A costs were primarily due to higher payroll and benefit costs due to additional employees and certain payroll increases, higher rent as we needed additional space for our operations, higher legal fees incurred due to increased compliance activities, higher stock compensation due to higher number of awards, higher commissions due to the Debentures issued in 2026, higher intangibles amortization as a result of the Azio acquisition described elsewhere,  partially offset by lower bad debts as all receivables from our electric vehicles segment were written-off at December 31, 2025, lower contract labor, lower licenses, lower utilities as we reduced activity in our Arkansas location and overall lower costs due to certain cost cutting measures that were implemented.

 

Consulting Expenses

 

Consulting expenses were $0 and $18,750 for the three months ended September 30, 2026 and 2025, respectively. Consulting expenses were $0 and $65,261 for the nine months ended September 30, 2026 and 2025, respectively. These costs were incurred primarily for certain consulting services related to our medical supplies segment.

 

18

 

Research and Development ("R&D") Expenses 

 

R&D expenses were $12,000 and $43,289 for the three months ended  September 30, 2026 and 2025, respectively. R&D expenses were $34,000 and $731,808 for the nine months ended  September 30, 2026 and 2025, respectively. R&D expenses incurred in 2026 was mainly for costs incurred in our AI data infrastructure segment while costs incurred in 2025 were mainly to build certain prototypes in our drones segment.

 

Goodwill Impairment Charge

 

Due to our declining stock price, we conducted an impairment test related to our goodwill in the first quarter of 2025. As a result of this test, we recorded an impairment charge of $10,103,048 related to our goodwill during the first quarter of 2025. 

 

Impairment of Intangible Assets

 

During the third quarter of 2025, we conducted an impairment test related to our intangible assets due to among other things, the business environment within the medical supplies segment. As a result of this test, we recorded a non-cash impairment charge of $3,300,801 for the three and nine months ended September 30, 2025. 

 

Gain/(Loss) in settlement of debt and changes in fair value of debt

 

We recorded a non-cash gain in settlement of debt and changes in fair value of debt of $330,175 for the three months ended September 30, 2026 and a non-cash loss in settlement of debt and changes in fair value of debt of $312,812 for the three months ended September 30, 2025, on our debt that we elected to measure at fair value. We recorded a non-cash loss in settlement of debt and changes in fair value of debt of $670,452 for the nine months ended September 30, 2026 and $963,513 for the nine months ended September 30, 2025, on our debt. 

 

Other expenses

 

Other expenses for the three months ended September 30, 2026 and 2025 were $11,743 and $3,530, respectively. Other expenses for the nine months ended September 30, 2026 and 2025 were $127,356 and $15,703, respectively.

 

Cash Flows

 

The following table summarizes our cash flows from operating, investing, and financing activities for the nine months ended September 30, 2026 and 2025:

 

   

Nine months ended September 30,

 
   

2026

   

2025

 

Cash flows used in operating activities

  $ (11,665,967 )   $ (6,295,792 )

Cash flows used in investing activities

    (5,148,364 )     (176,828 )

Cash flows provided by financing activities

    17,600,732       4,609,034  

Net change in cash

  $ 786,401     $ (1,863,586 )

 

Operating Activities 

 

Net cash used in operating activities for the nine months ended September 30, 2026 was $11,665,967, primarily due to a net loss of $16,365,922, primarily offset by changes in operating assets and liabilities, net of $681,056 and non-cash operating charges of 4,018,899. The changes in operating assets and liabilities, net were due to an increase in other non-current assets and ROU assets of $1,318,011, an increase in receivable from a related party of $651,432, a decrease in accrued liabilities of $344,905, a decrease in EPA contract liability for $23,625, partially offset by an increase in other liabilities for $906,495, a decrease in current assets of $326,001, an increase in accounts payable for $1,578,715, a decrease in EPA fulfillment asset of $160,511 and a decrease in prepaid expenses of $47,307.

 

Net cash used in operating activities for the nine months ended September 30, 2025 was $6,295,792, primarily due to a net loss of $25,540,675, partially offset by changes in operating assets and liabilities, net of $3,376,310 and non-cash operating charges of $15,868,573. The changes in operating assets and liabilities, net were due to a decrease in accounts receivable of $591,184, a decrease in inventory of $1,560,698 (as a result of an increase in reserves of $1,184,731), a decrease in prepaid expenses of $793,465, an increase in accounts payable of $1,461,854, an increase in accrued liabilities of $700,039, an increase in deferred revenue of $2,284,415 and an increase in other liabilities of $432,060, partially offset by an increase in receivables from a related party of $1,129,007, an increase of $2,743,291 in inventory deposits, an increase in other non-current assets of $481,795 (primarily from the establishment of a ROU asset) and an increase in current assets of $93,312.

 

 

Investing Activities

 

Net cash used in investing activities during the nine months ended September 30, 2026 was $5,148,364, primarily from the purchase of property and equipment used in our current operations related to our AI data infrastructure segment and the Azio acquisition described elsewhere in this filing.

 

Net cash used in investing activities during the nine months ended September 30, 2025 was $176,828, primarily from the purchase of property and equipment used in our current operations.

 

Financing Activities

 

Net cash provided by financing activities during the nine months ended September 30, 2026 was $17,600,732 primarily from the issuance of the common stock for $2,975,000, issuance of the Debentures of $13,415,000, proceeds from our Credit Facility for $1,765,000, proceeds from exercise of warrants for $7,419, partially offset repayment of the Debentures for $500,000 and net repayment of other debt for $61,687.

 

Net cash provided by financing activities during the nine months ended September 30, 2025 was $4,609,034 primarily from the issuance of the Additional Promissory Notes for $4,750,500 in net proceeds, partially offset by loan repayments of $141,466.

 

19

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had cash of $1,145,367 and negative working capital of approximately $19,398,536. To date, we have financed our operations primarily through capital raises from issuing common stock. We believe that our existing cash may not be sufficient to allow us to operate for the next 12 months due to our current and potential liabilities. We may need to raise additional capital through equity or debt issuances. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations and reducing overhead expenses. We cannot provide any assurance that any new financing will be available on commercially acceptable terms, if at all, or will be completed on a timely basis. These conditions raise substantial doubt about our ability to continue as a going concern. 

 

The accompanying unaudited consolidated financial statements were prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The accompanying unaudited consolidated financial statements do not include any adjustments that might be necessary if we were unable to continue as a going concern.

 

Amended and Restated Standby Equity Purchase Agreement 

 

On October 31, 2024, we entered into the Amended and Restated Standby Equity Purchase Agreement (the “A&R SEPA”) with YA II PN, Ltd. (the "Investor"). The A&R SEPA amends and restates in its entirety the standby equity purchase agreement, dated September 23, 2024, by and between the Company and the Investor (the “Original SEPA”).

 

Pursuant to the A&R SEPA, except for so long as there is a balance outstanding under the Promissory Notes (as defined below) and the Additional Promissory Notes (as defined below), we have the right, from time to time, until November 1, 2027, to require the Investor to purchase up to $25 million of shares of our common stock, subject to certain limitations and conditions set forth in the A&R SEPA, by delivering written notice to the Investor. Pursuant to the A&R SEPA, the Investor advanced to us the principal amount of $3 million (the “Pre-Paid Advance”) in exchange for our issuance to the Investor of convertible promissory notes (the “Promissory Notes”) in two tranches, resulting in net proceeds (net of discounts and fees) to us of $2,635,500. We received the first tranche of the Pre-Paid Advance in the principal amount of $2 million on October 31, 2024 in exchange for the Promissory Note dated October 31, 2024 (the “EVTV-1 Promissory Note”), and the second tranche of the Pre-Paid Advance in the principal amount of $1 million on December 17, 2024 in exchange for the Promissory Note dated December 17, 2024 (the “EVTV-2 Promissory Note”). The Promissory Notes accrued interest on the outstanding principal balance at an annual rate equal to 0%, which would increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Promissory Notes) or a Registration Event (as defined in the Promissory Notes) for so long as such event of default remained uncured. Prior to our entry into the Supplemental Agreement (as defined below), the Promissory Notes were initially set to mature on November 13, 2025 and were convertible at a conversion price equal to the lower of (i) $21.48 per share or (ii) 93% of the lowest daily volume weighted average price of our common stock on Nasdaq as reported by Bloomberg L.P. (“VWAP”) during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which was $3.58 per share, subject to adjustment from time to time in accordance with the terms contained in the Promissory Notes). Pursuant to the terms of the Original SEPA, we issued 6,410 shares of common stock to the Investor as a commitment fee.

 

During 2025, the obligation under the EVTV-1 Promissory Note was partially satisfied through the conversion of the EVTV-1 Promissory Note into shares of our common stock. As a result of this conversion, 1,416,116 shares of our common stock were issued at a weighted average price of $1.06. The remaining principal balance of the EVTV-1 Promissory Note at December 31, 2025, was $285,000. The remaining obligation was fully satisfied through the conversion of the EVTV-1 Promissory Note into shares of our common stock during the first quarter of 2026. As a result of this conversion, 529,096 shares of our common stock were issued at a weighted average price of $0.63.

 

We have elected to measure the Promissory Notes at fair value. In estimating the fair value of the Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the common stock. The Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by Accounting Standards Codification ("ASC") 820. All debt obligations under the Promissory Notes were fully satisfied at September 30, 2026.

 

Supplemental Agreement to A&R SEPA 

 

On February 24, 2025, we entered into a supplemental agreement, dated February 24, 2025 (the “Supplemental Agreement”), with the Investor, which amends and supplements the A&R SEPA to: (i) provide for the advancement by the Investor to us, subject to the satisfaction of certain conditions as set forth in the Supplemental Agreement, of $5 million under the A&R SEPA (the “Additional Pre-Paid Advance”), to be evidenced by convertible promissory notes (the “Additional Promissory Notes”) in two tranches, (ii) amend the maturity date for the EVTV-1 Promissory Note to March 9, 2026, and (iii) amend the floor price for the EVTV-1 Promissory Note to $0.7130 per share.

 

The Additional Promissory Notes accrued interest on the outstanding principal balance at an annual rate equal to 5%, which would increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Additional Promissory Notes) or a Registration Event (as defined in the Additional Promissory Notes) for so long as such event remained uncured. The Additional Promissory Notes were scheduled to mature on March 9, 2026. The Additional Promissory Notes were convertible at a conversion price equal to the lower of (i) $10.00 per share or (ii) 93% of the lowest daily VWAP during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $0.7130 per share, subject to adjustment from time to time in accordance with the terms contained in the Additional Promissory Notes).

 

The first tranche of the Additional Pre-Paid Advance was disbursed on February 25, 2025 in the principal amount of $3 million (with net proceeds to us of approximately $2.7 million after deducting discounts and fees) as evidenced by an Additional Promissory Note issued by us to the Investor on February 24, 2025 (the “EVTV-3 Additional Promissory Note”). During 2025, the obligation under the EVTV-3 Additional Promissory Note in the principal amount of $3 million was partially satisfied through the conversion of the EVTV-3 Additional Promissory Note into shares of our common stock. As a result of this conversion, 2,134,613 shares of our common stock were issued at a weighted average price of $1.51. The remaining principal balance of the EVTV-3 Additional Promissory Note on December 31, 2025, was $50,000. The remaining obligation was fully satisfied through the conversion of the EVTV-3 Additional Promissory Note into shares of our common stock during the first quarter of 2026. As a result of this conversion, 94,657 shares of the common stock were issued at a weighted average price of $0.53. 

 

We have elected to measure the Additional Promissory Notes at fair value. In estimating the fair value of the Additional Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of our common stock. The Additional Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. All debt obligations under the Additional Promissory Notes were fully satisfied at September 30, 2026.

 

Debenture Financing

 

On March 6, 2026, we entered into a securities purchase agreement (the “SPA”) with the Investor, pursuant to which the Company agreed to issue and sell to the Investor, and the Investor agreed to purchase, debentures the “Debentures” in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches with the purchase price of the Debentures in each tranche being equal to 96% of the Subscription Amount to be purchased. The closing of the initial tranche of Debentures occurred on March 6, 2026 (the “First Closing”), in which we issued Debentures in the aggregate principal amount of $4,000,000 (the “First Closing Debentures”) to the Investor. The closing of the second tranche of the remaining $7,000,000 in aggregate principal amount of the Debentures (the “Second Closing” and such Debentures, the “Second Closing Debentures”) occurred on May 6, 2026.

 

In addition, in connection with the First Closing, as a commitment fee for the transactions contemplated by the SPA, we issued to the Investor warrants to purchase up to 1,291,778 shares of our common stock at an exercise price of $0.01 per share (the “Debentures Warrants”). The Debenture Warrants are immediately exercisable and will expire 60 months from the date of issuance. The Warrants include customary adjustment provisions for stock splits, combinations and similar events.

 

The Debentures bear interest at a rate of 5.0% per annum, subject to a potential increase to 18.0% per annum upon the occurrence of certain events of default. The Debentures mature on March 6, 2027 (the “Maturity Date”). We will repay the outstanding principal of the Debentures in monthly installments of (i) $363,636 for the First Closing Debentures and (ii) $636,364 for the Second Closing Debentures, in each case, plus accrued and unpaid interest, in cash, beginning on May 5, 2026. Any outstanding principal amount of, and accrued and unpaid interest on, the Debentures as of the Maturity Date will be due and payable on the Maturity Date.

 

The Debentures provide us with an optional redemption right pursuant to which we, at any time, may redeem in cash, in whole or in part, all amounts outstanding under the Debentures prior to the Maturity Date. The redemption amount shall be equal to the outstanding principal balance of the Debentures being redeemed by us, plus all accrued and unpaid interest thereon as of such redemption date. The outstanding principal balance at September 30, 2026 was $8,809,267.

 

Standby Equity Purchase Agreement

 

On September 25, 2026, the Company entered into a standby equity purchase agreement (the “SEPA”) with the Investor. Pursuant to the SEPA, the Investor will advance to the Company, subject to the satisfaction of certain conditions, an aggregate principal amount of $3.5 million (the “Azio Pre-Paid Advance”), which shall be evidenced by convertible promissory notes in two tranches (the "Azio Promissory Notes"). The Azio Promissory Notes will accrue interest at an annual rate equal to 6%, which shall increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Azio  Promissory Notes) for so long as such event remains uncured. The Azio Promissory Notes will mature on September 25, 2027, which may be extended at the option of the Investor. The Investor has the right to convert into shares of Common Stock (i) in the case of a Payment Failure (as defined in the Azio Promissory Notes), all or part of the applicable Monthly Payment Amount (as defined in the Azio Promissory Notes) at any time after such Payment Failure has occurred into shares of Common Stock or (ii) in the case of an Event of Default (as defined in the Azio Promissory Notes), if such Event of Default has not been cured or waived in writing by the Investor, all or part of the Azio Promissory Note at any time after the occurrence of an Event of Default and so long as the applicable Event of Default is continuing, in each case, at a conversion price equal to 92% of the lowest daily VWAP during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $0.26 per share, subject to adjustment from time to time in accordance with the terms contained in the Azio Promissory Notes).

 

The first tranche of the Azio Pre-Paid Advance was disbursed on September 25, 2026, in the principal amount of $3.0 million (with net proceeds of approximately $2.2 million to the Company after deducting for discount and fees). The second tranche of the Azio Pre-Paid Advance will be in the principal amount of $0.5 million and advanced on the second trading day after the registration statement covering the resale of shares issuable pursuant to Advances (as defined below) under the SEPA and shares underlying the SEPA Warrants (as defined below) (the "SEPA Resale Registration Statement") first becomes effective. At the closing of each tranche of the Azio Pre-Paid Advance, the Investor will advance to the Company the principal amount of the applicable tranche of the Pre-Paid Advance, less a discount in the amount equal to 4% of the principal amount of such tranche of the Azio Pre-Paid Advance netted from the purchase price due and structured as an original issue discount.

 

Pursuant to the SEPA, and upon the satisfaction of the conditions to the Investor’s purchase obligation set forth in the SEPA the Company will have the right, from time to time, until termination or expiration of the SEPA, to require the Investor to purchase up to $50 million (the “Commitment Amount”) of shares of Common Stock, subject to certain limitations and conditions set forth in the SEPA, by delivering written notice to the Investor (“Advance Notice” and the issuance and sale of such shares as specified therein, an “Advance”). The Company may, in its sole discretion, select the amount of the Advance that the Company desires to issue and sell to the Investor in each Advance Notice, subject to a maximum limit equal to 100% of the average of the daily volume traded of the Common Stock on the Nasdaq Capital Market for the five consecutive trading days immediately preceding the delivery of an Advance Notice (the “Maximum Advance Amount”).

 

For so long as any amount remains outstanding under the Promissory Notes or under the Debentures issued pursuant to the SPA, the Company may only, except with the prior written consent of the Investor, submit an Advance Notice if the aggregate purchase price owed to the Company from such Advances (the “Advance Proceeds”) shall be paid by the Investor by offsetting the amount of the Advance Proceeds against an equal amount outstanding under the subject Promissory Note or Debentures (applied first towards accrued and unpaid interest, and then towards outstanding principal).

 

The shares of Common Stock to be purchased pursuant to an Advance Notice will be issued and sold to the Investor at a per share price equal to, at the Company’s election as specified in the relevant Advance Notice: (i) 96% of the Market Price (as defined below) for any period commencing upon the receipt of the Advance Notice by the Investor and ending at 4:00 p.m., Eastern Time, on the same trading day, unless otherwise agreed by the parties (the “Option 1 Pricing Period”), or (ii) 97% of the Market Price for the three consecutive trading days commencing on the day such Advance Notice is delivered (the “Option 2 Pricing Period,” and each of the Option 1 Pricing Period and the Option 2 Pricing Period, a “Pricing Period”). “Market Price” is defined as, for any Option 1 Pricing Period, the daily VWAP of the Common Stock on the Nasdaq Capital Market as reported by Bloomberg L.P. during the Option 1 Pricing Period, and for any Option 2 Pricing Period, the lowest daily VWAP of the Common Stock during the Option 2 Pricing Period.

 

If, with respect to an Option 1 Pricing Period, the total number of shares of Common Stock traded on the Nasdaq Capital Market during the applicable Pricing Period is less than the Volume Threshold (as defined below), then the number of shares of Common Stock issued and sold pursuant to such Advance Notice will be reduced to the greater of (i) 30% of the trading volume of the Common Stock on the Nasdaq Capital Market during the relevant Pricing Period as reported by Bloomberg L.P. or (ii) the number of shares of Common Stock sold by the Investor during such Pricing Period, but in each case not to exceed the amount requested in the Advance Notice. “Volume Threshold” is defined as a number of shares of Common Stock equal to the quotient of (i) the number of shares requested by the Company in the Advance Notice divided by (ii) 0.30.

 

As consideration for its commitment to purchase shares of Common Stock at the Company’s request under the SEPA, the Company issued to the Investor, upon execution of the SEPA, warrants exercisable for the purchase of an aggregate of 1,735,758 shares of Common Stock (the “SEPA Warrants” and the shares of Common Stock underlying such SEPA Warrants, the “Commitment Shares”) at an exercise price of $0.01 per share. In addition, the Company paid a structuring fee to the Investor in an aggregate amount of $50,000 which was paid from a portion of the proceeds of the initial Azio Pre-Paid Advance.

 

The SEPA will automatically terminate on the earliest to occur of (i) September 25, 2029, subject to delay until the Promissory Notes and the Debentures have been repaid in full, or (ii) the date on which the Investor shall have purchased from the Company under the SEPA the Commitment Amount in full. The Company may terminate the SEPA at any time upon five trading days’ prior written notice to the Investor, provided that there are no outstanding Advance Notices under which the Company is yet to issue Common Stock and provided that the Company has paid all amounts owed to the Investor pursuant to the SEPA and the Azio Promissory Notes. The Company and the Investor may also agree to terminate the SEPA by mutual written consent. Neither the Company nor the Investor may assign or transfer their respective rights and obligations under the SEPA, and no provision of the SEPA may be modified or waived by the Company or the Investor other than by an instrument in writing signed by both parties.

 

Capital Expenditures

 

We do not have any contractual obligations for ongoing capital expenditures at this time. We do, however, purchase equipment necessary to conduct our operations on an as needed basis and will continue increasing those expenditures as deemed necessary in our business operations.

 

Contractual Obligations

 

Other than as disclosed in the unaudited consolidated financial statements in Item 1 of this Quarterly Report for the period ended September 30, 2026, we have no contractual obligations.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

Our consolidated financial statements are prepared in accordance with U.S generally accepted accounting principles ("GAAP"). The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.

 

We define our critical accounting policies as those accounting principles under GAAP that require us to make subjective estimates and judgments about matters that are uncertain and are likely to have a material impact on our financial condition and results of operations as well as the specific manner in which we apply those principles.

 

Smaller Reporting Company Status

 

We are a “smaller reporting company” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the "exchange Act"). We may continue to be a smaller reporting company if either (i) the market value of our shares held by non-affiliates is less than $250 million measured on the last business day of our most recently completed second fiscal quarter or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our shares held by non-affiliates is less than $700 million as of the last business day of our most recently completed second fiscal quarter. We may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not smaller reporting companies, including reduced disclosure about our executive compensation arrangements.

 

20

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) for the quarter ended September 30, 2026. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of such time due to the material weakness described below.

 

In connection with the preparation of the financial statements for the quarter ended September 30, 2026, management identified a deficiency in the design of controls over the review of assumptions used to value stock-based compensation awards. Management has concluded this deficiency constitutes a material weakness and is a component of the material weakness previously disclosed in Item 9A of the 2025 Form 10-K. The expected volatility input used in the Black-Scholes model to value the stock options granted on May 22, 2026 was computed from the dispersion of daily stock price levels rather than from the historical volatility of daily stock returns, and the valuation inputs were reviewed only by the preparer. This deficiency resulted in an understatement of non-cash stock-based compensation expense of $860,428 for the three months ended June 30, 2026, which we corrected as an out-of-period adjustment in the three months ended September 30, 2026, as described in Note 2 to our unaudited consolidated financial statements included in this Quarterly Report. Management evaluated the severity of this deficiency, individually and in combination with the existing material weaknesses described above and concluded that it constitutes an additional material weakness as it is a further manifestation of, and is included within, the existing material weaknesses related to insufficient accounting resources.

 

In making such conclusion, our management determined that such deficiencies were determined to be material weaknesses that are primarily due to a lack of number of employees since the beginning of the fourth quarter of 2020 and such deficiencies continue through the date of this filing. During such periods and for all periods thereafter through the date of such determination, we increased our reliance on outsourced accounting help. As a result of such changes, our management concluded that we were unable to maintain the levels of resources during such periods at the levels of prior periods, and that such changes to our procedures significantly affected our internal control over financial reporting during the quarter ended September 30, 2026.


 

Changes in Internal Control over Financial Reporting

 

Except as described above, there was no change in the Company’s internal control over financial reporting during the most recent three-month period covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

21

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Except as described in Note 11 - Commitments and Contingencies, there were no material developments during the quarter ended September 30, 2026 in the legal proceedings described in our Annual Report on Form 10-K for the year ended December 31, 2025

 

ITEM 1A. RISK FACTORS

 

There were no material changes from the risk factors previously disclosed in our 2025 Annual Report  and under Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the SEC on August 18, 2026. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On July 31, 2026, the Company entered into a marketing agreement whereby the Company agreed to issue 167,112 shares of its common stock in exchange for marketing services to be performed from August 7, 2026 through February 8, 2027. The issuance of these shares of common stock pursuant to the marketing agreement was and will be made in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

   

 

ITEM 5. OTHER INFORMATION

 

None.

 

22

   
 

ITEM 6. EXHIBITS

 

A list of exhibits is set forth at the end of this Quarterly Report for the information required by this item.

 

           

Incorporated by

Reference

       

Exhibit

Number

 

Exhibit Description

 

Form

 

File No.

 

Exhibit

 

Filing

Date

 

Filed

Herewith

                         

2.1**

 

Amended and Restated Agreement and Plan of Merger, dated as of July 2, 2026, by and among Envirotech Vehicles, Inc., Azio AI Corporation, EV-AZ Merger Sub, Inc. and Azio AI, LLC

 

8-K

 

001-38078

 

2.1

 

7/6/2026

   

3.1

 

Amended and Restated Certificate of Incorporation of the Company

 

1-A POS

 

024-10656

 

2.7

 

6/15/2017

   

3.2

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on June 8, 2018

 

8-K

 

001-38078

 

3.1

 

6/11/2018

   

3.3

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on May 26, 2021

 

8-K

 

001-38078

 

3.1

 

6/2/2021

   

3.4

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on June 24, 2022

 

8-K

 

001-38078

 

3.1

 

6/28/2022

   

3.5

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on August 6, 2025

 

8-K

 

001-38078

 

3.1

 

8/6/2025

   

3.6

 

Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock, dated July 2, 2026

 

8-K

 

001-38078

 

3.1

 

7/6/2026

   

3.7

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective July 9, 2026

 

8-K

 

001-38078

 

3.1

 

7/10/2026

   

3.8

 

Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock of Azio AI Holdings, Inc., effective September 15, 2026.

 

8-K

 

001-38078

 

3.1

 

9/17/2026

   

3.9

 

Second Amended and Restated Bylaws, dated as of July 9, 2026

 

8-K

 

001-38078

 

3.2

 

7/10/2026

   

10.1

 

Registration Rights Agreement, dated July 2, 2026, by and among the Company and the Selling Securityholders named therein

 

8-K

 

001-38078

 

10.3

 

7/6/2026

   

10.2

 

Standby Equity Purchase Agreement, dated September 25, 2026, by and between Azio AI Holdings, Inc. and YA II PN, Ltd.

 

8-K

 

001-38078

 

10.1

 

9/28/2026

   

10.3

 

Form of Convertible Promissory Note

 

8-K

 

001-38078

 

10.2

 

9/28/2026

   

10.4

 

Registration Rights Agreement, dated September 25, 2026, by and between Azio AI Holdings, Inc. and YA II PN, Ltd.

 

8-K

 

001-38078

 

10.3

 

9/28/2026

   

10.7

 

Form of Warrant to YA II PN, LTD, dated September 25, 2026

 

8-K

 

001-38078

 

4.1

 

9/28/2026

   

10.5

 

Revolving Credit Facility Agreement, dated October 21, 2026, by and between, Azio AI Holdings, Inc. and Azio Corporation

 

8-K

 

001-38078

 

10.1

 

10/23/2026

   

10.6

 

Revolving Promissory Note, dated October 21, 2026, by Azio AI Holdings, Inc. in favor of Azio Corporation

 

8-K

 

001-38078

 

10.2

 

10/23/2026

   

31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

                 

X

31.2

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

                 

X

32.1#

 

18 U.S.C. Section 1350 Certification of Chief Executive Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

                 

X

32.2#

 

18 U.S.C. Section 1350 Certification of Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

                 

X

101.INS

 

Inline XBRL Instance Document*

                 

X

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document*

                 

X

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

                 

X

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document*

                 

X

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

                 

X

101.DEF

 

Inline XBRL Taxonomy Extension Definitions Linkbase Document*

                 

X

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

                   

 

#

The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.

*

In accordance with Rule 402 of Regulation S-T, this interactive data file is deemed not filed or part of this Quarterly Report for purposes of Sections 11 or 12 of the Securities Act or Section 18 of the Exchange Act and otherwise is not subject to liability under these sections.

**

Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules or exhibits on a confidential basis upon request.

 

23

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Azio AI Holdings Inc.

 
     

Date: November 18, 2026

By:

/s/ Chris Young

 
   

Chris Young

 
   

Chief Executive Officer

 
   

(Principal Executive Officer)

 
       
Date: November 18, 2026

By:

/s/ Jason Maddox

 
   

Jason Maddox

 
   

Chief Financial Officer

 
   

(Principal Financial and Accounting Officer)

 

 

24

Keep reading